FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Scardino

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Peter T Scardino
Prostate cancer: Improving PSA testing by adjusting for genetic background.
Sigrid V Carlsson; Daher C Chade; James Eastham; Samson W Fine; Niccolo Passoni; Peter T Scardino; Shahrokh F Shariat; Daniel D Sjoberg; Laura J Tafe; Karim Touijer
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.
Kazuma Udo; Hikmat Al-Ahmadie; Lauren J Carlino; Angel M Cronin; James A Eastham; Anuradha Gopalan; Alexandra C Maschino; Victor E Reuter; Caroline J Savage; Peter T Scardino; SK Tickoo; Samson W Fine
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Scardino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter T Scardino
Prostate cancer: Improving PSA testing by adjusting for genetic background.
Nature reviews. Urology 2013;10(4):190-2.
2013: Sigrid V Carlsson; Daher C Chade; James Eastham; Samson W Fine; Niccolo Passoni; Peter T Scardino; Shahrokh F Shariat; Daniel D Sjoberg; Laura J Tafe; Karim Touijer
Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.
The Journal of urology 2013;189(4):1314-9.
2013: Kazuma Udo; Hikmat Al-Ahmadie; Lauren J Carlino; Angel M Cronin; James A Eastham; Anuradha Gopalan; Alexandra C Maschino; Victor E Reuter; Caroline J Savage; Peter T Scardino; SK Tickoo; Samson W Fine
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.
The Journal of urology 2013;189(4):1302-7.
2013: Patrick E Teloken; James Eastham; Michael Karellas; Christian J Nelson; Peter T Scardino; Jason Stasi; John P Mulhall
Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy.
BJU international 2013;111(4):653-7.
2013: Jonathan Coleman; Peter T Scardino
Targeted prostate cancer ablation: energy options.
Current opinion in urology 2013;23(2):123-8.
2013: G Fisher; S Kudahetti; Henrik Møller; Peter T Scardino; Z H Yang; D M Berney; Jack Cuzick
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.
British journal of cancer 2013;108(2):271-7.
2013: Jonathan L Silberstein; Daniel Su; Andrew J Vickers; Peter T Scardino; Jonathan Coleman; James A Eastham; Leonard Glickman; Matthew Kent; Gal Keren-Paz; Vincent Laudone
A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons.
BJU international 2013;111(2):206-12.
2013: Toshiaki Yoshioka; Brett Carver; Yu Chen; Elisa de Stanchina; Katsuhiko Enomoto; Norman M Greenberg; Young-Mi Kim; Jason A Koutcher; Javier Otero; Victor Reuter; Jaya Satagopan; Charles L Sawyers; Peter T Scardino; Howard I Scher; Filippo G Giancotti
β4 Integrin signaling induces expansion of prostate tumor progenitors.
The Journal of clinical investigation 2013;123(2):682-99.
2013: Andrew J Vickers; Caroline J Bennette; Anders Bjartell; Thomas Björk; Anders Dahlin; Axel Gerdtsson; Jonas Manjer; Peter M Nilsson; Peter T Scardino; Daniel D Sjoberg; David Ulmert; Hans Lilja
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.
BMJ (Clinical research ed.) 2013;346():f2023.
2013: Scott E Eggener; Larry Goldenberg; Robert Abouassaly; Raj Ayyathurai; Ryan K Berglund; James A Eastham; Steven J Jones; Eric A Klein; Alex Mueller; Peter T Scardino; Mark S Soloway; Cindy Soloway; Chris Zappavigna; Bertrand Guillonneau
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2013;189(1 Suppl):S19-25; discussion S25.
2012: Hebert Alberto Vargas; Kristen L Zakian; Jingbo Zhang; Junting Zheng; Oguz Akin; James A Eastham; Debra A Goldman; Kent Kanao; Chaya S Moskowitz; Victor E Reuter; Peter T Scardino; Amita Dave; Hedvig Hricak
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.
Radiology 2012;265(2):478-87.
2012: Andrew J Vickers; James A Eastham; Peter T Scardino
Radical prostatectomy versus observation for prostate cancer.
The New England journal of medicine 2012;367(15):1467-8; author reply 1468-9.
2012: Anuj Goenka; Marisa Kollmeier; Juan Martin Magsanoc; Xin Pei; Peter T Scardino; Michael Schechter; Brett Cox; James A Eastham; Michael J Zelefsky
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
International journal of radiation oncology, biology, physics 2012;84(1):112-8.
2012: Kazuhito Matsushita; Badar M Mian; Peter T Scardino; Melanie Bernstein; Bernard H Bochner; Bilal I Chughtai; Elise De; James A Eastham; Lauren Ginsburg; Jaspreet S Sandhu
Pubovesical fistula: a rare complication after treatment of prostate cancer.
Urology 2012;80(2):446-51.
2012: Behfar Ehdaie; Coral L Atoria; James A Eastham; Andrew Feifer; Amit Gupta; William T Lowrance; Michael J Morris; Peter T Scardino; Elena B Elkin
Androgen deprivation and thromboembolic events in men with prostate cancer.
Cancer 2012;118(13):3397-406.
2012: William T Lowrance; Peter T Scardino; David S Yee; Brian Denton; James A Eastham; Vincent Laudone; Elena B Elkin
Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis.
Cancer 2012;118(12):3079-86.
2012: William T Lowrance; A C Maschino; Christopher B Dechet; James A Eastham; Vincent Laudone; Caroline Savage; Peter T Scardino; Robert A Stephenson; Jaspreet S Sandhu
Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States.
The Journal of urology 2012;187(6):2087-92.
2012: Guilherme Godoy; Peter T Scardino; Christian von Bodman; Daher C Chade; Ozdal Dillioglugil; James A Eastham; Samson W Fine; Vincent Laudone
Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
The Journal of urology 2012;187(6):2082-6.
2012: Jonathan L Silberstein; Karim Touijer; Andrew J Vickers; Jonathan Coleman; James A Eastham; Raul O Parra; Rodrigo Pinochet; Nicholas E Power; Peter T Scardino; Vincent Laudone
Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures.
Journal of endourology / Endourological Society 2012;26(6):748-53.
2012: Daher C Chade; James Eastham; Markus Graefen; Jim C Hu; R Jeffrey Karnes; Laurence Klotz; Francesco Montorsi; Peter T Scardino; Hendrik van Poppel; Shahrokh F Shariat
Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
European urology 2012;61(5):961-71.
2012: William T Lowrance; Peter T Scardino; Howard I Scher; David S Yee; Michael J Zelefsky; Behfar Ehdaie; Elena B Elkin; Andrew Feifer; Lindsay M Jacks; Coral L Atoria; James A Eastham
Locally advanced prostate cancer: a population-based study of treatment patterns.
BJU international 2012;109(9):1309-14.
2012: Clarisse Mazzola; Victor E Reuter; Caroline Savage; Peter T Scardino; Youness Ahallal; James A Eastham; Bertrand Guillonneau; Karim Touijer
Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
BJU international 2012;109(9):1323-8.
2012: Amita Dave; Kazuma Udo; Changhong Yu; Kristen L Zakian; Oguz Akin; James A Eastham; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
BJU international 2012;109(9):1315-22.
2012: David Ulmert; John Wongvipat; Peter T Scardino; Per-Anders Abrahamsson; Michael J Evans; Jason P Holland; Steven M Larson; Jason S Lewis; Hans Lilja; Kim Pettersson; Samuel L Rice; Charles L Sawyers
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
Cancer discovery 2012;2(4):320-7.
2012: Jack Cuzick; G Fisher; Christopher S Foster; A Gutin; J S Lanchbury; D Mesher; Henrik Møller; J Park; M Perry; J E Reid; Peter T Scardino; S Stone; A Younus; D M Berney
Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.
British journal of cancer 2012;106(6):1095-9.
2012: Christian von Bodman; Caroline Savage; Peter T Scardino; Oguz Akin; James A Eastham; Mika P Matikainen; Kazuhito Matsushita; Farhang Rabbani; Jaspreet S Sandhu
Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging.
The Journal of urology 2012;187(3):945-50.
2012: Robert J Klein; Anders Bjartell; Anders Dahlin; Amit Gupta; Christer Hallden; Jonas Manjer; Caroline J Savage; Peter T Scardino; David Ulmert; Andrew J Vickers; Peter Wallström; Hans Lilja
Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
European urology 2012;61(3):471-7.
2012: David J Gallagher; Matthew I Milowsky; Michael J Morris; Kenneth Offit; Jasmine Bhatia; Angel M Cronin; James A Eastham; Peter T Scardino; Mark Robson
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.
BJU international 2012;109(5):713-9.
2012: Raanan Tal; Farhang Rabbani; Peter T Scardino; John P Mulhall
Measuring erectile function after radical prostatectomy: comparing a single question with the International Index of Erectile Function.
BJU international 2012;109(3):414-7.
2012: Andrew J Vickers; Karim Touijer; Caroline Bennette; Brett Carver; Jonathan Coleman; James A Eastham; Vincent Laudone; Peter T Scardino
Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy.
Trials 2012;13():23.
2011: Anuj Goenka; Marisa Kollmeier; Juan Martin Magsanoc; Xin Pei; Peter T Scardino; Michael Schechter; Brett Cox; James A Eastham; Michael J Zelefsky
Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
European urology 2011;60(6):1142-8.
2011: Jonathan L Silberstein; Andrew J Vickers; James A Eastham; Samson W Fine; Nicholas E Power; Peter T Scardino; Vincent Laudone
Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy.
Cancer 2011;117(21):4855-60.
2011: Christian von Bodman; Peter T Scardino; Oguz Akin; James A Eastham; Mika P Matikainen; Kazuhito Matsushita; Farhang Rabbani
Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy?
BJU international 2011;108(10):1566-71.
2011: Andrew H Feifer; Lindsay Jacks; Vincent Laudone; William T Lowrance; Peter T Scardino; David S Yee; Jonathan Coleman; Brian Denton; Elena B Elkin; James A Eastham
Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.
Cancer 2011;117(17):3933-42.
2011: Daher C Chade; Angel M Cronin; Marcos Dall'Oglio; Michael L Blute; Alberto Briganti; Martin E Gleave; Guilherme Godoy; Antonio Hurtado-coll; Steven Joniau; R Jeffrey Karnes; Francesco Montorsi; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; Miguel Srougi; Henk G van der Poel; Hendrik Van Poppel; James A Eastham
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
European urology 2011;60(2):205-10.
2011: Guilherme Godoy; Bertrand Guillonneau; Vincent Laudone; Peter T Scardino; Karim Touijer; Andrew Vickers; Kian Tai Chong; Angel Cronin; James A Eastham; Jonathan Coleman
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
European urology 2011;60(2):195-201.
2011: David S Yee; Angel M Cronin; William T Lowrance; Alexandra C Maschino; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; James A Eastham
Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
BJU international 2011;108(4):502-7.
2011: Jaspreet S Sandhu; Geoffrey T Gotto; Luis A Herran; Peter T Scardino; James A Eastham; Farhang Rabbani
Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.
The Journal of urology 2011;185(6):2148-52.
2011: Brett S Carver; Caren Chapinski; John Wongvipat; Haley Hieronymus; Yu Chen; Sarat Chandarlapaty; Vivek K Arora; Carl Le; Jason Koutcher; Howard Scher; Peter T Scardino; Neal Rosen; Charles L Sawyers
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer.
Cancer cell 2011;19(5):575-86.
2011: M Frank O'Brien; Angel M Cronin; Paul Fearn; Caroline J Savage; Brandon Smith; Jason Stasi; Peter T Scardino; Gabrielle Fisher; Jack Cuzick; Henrik Møller; R Timothy Oliver; Daniel M Berney; Christopher S Foster; James A Eastham; Andrew J Vickers; Hans Lilja
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively.
International journal of cancer. Journal international du cancer 2011;128(10):2373-81.
2011: Rebecca S Guest; Ray Baser; Yuelin Li; Peter T Scardino; Arthur E Brown; David W Kissane
Cancer surgeons' distress and well-being, I: the tension between a culture of productivity and the need for self-care.
Annals of surgical oncology 2011;18(5):1229-35.
2011: Rebecca S Guest; Ray Baser; Yuelin Li; Peter T Scardino; Arthur E Brown; David W Kissane
Cancer surgeons' distress and well-being, II: modifiable factors and the potential for organizational interventions.
Annals of surgical oncology 2011;18(5):1236-42.
2011: James A Eastham; Peter T Scardino
The devil is in the details.
European urology 2011;59(5):708-9; discussion 710-1.
2011: Mark A Preston; Mathieu Carrière; Gaayana Raju; Christopher Morash; Steve Doucette; Ronald G Gerridzen; Anthony J Bella; James A Eastham; Peter T Scardino; Ilias Cagiannos
The prognostic significance of capsular incision into tumor during radical prostatectomy.
European urology 2011;59(4):613-8.
2011: Andrew J Vickers; Caroline J Savage; Fernando J Bianco; Eric A Klein; Michael W Kattan; Fernando P Secin; Bertrand D Guilloneau; Peter T Scardino
Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.
International journal of cancer. Journal international du cancer 2011;128(7):1697-702.
2011: Hans Lilja; Angel M Cronin; Anders Dahlin; Jonas Manjer; Peter M Nilsson; James A Eastham; Anders S Bjartell; Peter T Scardino; David Ulmert; Andrew J Vickers
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
Cancer 2011;117(6):1210-9.
2011: Scott E Eggener; Peter T Scardino; Patrick C Walsh; Misop Han; Alan W Partin; Bruce J Trock; Zhaoyong Feng; David P Wood; James A Eastham; Ofer Yossepowitch; Danny M Rabah; Michael W Kattan; Changhong Yu; Eric A Klein; Andrew J Stephenson
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
The Journal of urology 2011;185(3):869-75.
2011: Jochen Walz; Steven Joniau; fianceeyi chun; Hendrik Isbarn; Claudio Jeldres; Ofer Yossepowitch; Hsu Chao-Yu; Eric A Klein; Peter T Scardino; Alwyn M Reuther; Hein Van Poppel; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
BJU international 2011;107(5):765-70.
2011: Ari Adamy; David S Yee; Kazuhito Matsushita; Alexandra Maschino; Angel Cronin; Andrew Vickers; Bertrand Guillonneau; Peter T Scardino; James A Eastham
Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.
The Journal of urology 2011;185(2):477-82.
2011: Andrew J Vickers; Amit Gupta; Caroline J Savage; Kim Pettersson; Anders Dahlin; Anders Bjartell; Jonas Manjer; Peter T Scardino; David Ulmert; Hans Lilja
A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):255-61.
2011: Christian von Bodman; Mika P Matikainen; Ricardo L Favaretto; Kazuhito Matsushita; John P Mulhall; James A Eastham; Peter T Scardino; Oguz Akin; Farhang Rabbani
Pelvimetric dimensions do not impact upon nerve sparing or erectile function recovery in patients undergoing radical retropubic prostatectomy.
The journal of sexual medicine 2011;8(2):567-74.
2011: Gustavo E Ayala; Bahar Muezzinoglu; Kai H Hammerich; Anna Frolov; Hao Liu; Peter T Scardino; Rile Li; Mohammad Sayeeduddin; Michael Ittmann; Dov Kadmon; Brian J Miles; Thomas M Wheeler; David R Rowley
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens.
The American journal of pathology 2011;178(1):79-87.
2011: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Victor Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011;24(1):58-63.
2011: Daniel J Moskovic; Hannah Alphs; Christian J Nelson; Farhang Rabbani; James Eastham; Karim Touijer; Bertrand Guillonneau; Peter T Scardino; John P Mulhall
Subjective characterization of nerve sparing predicts recovery of erectile function after radical prostatectomy: defining the utility of a nerve sparing grading system.
The journal of sexual medicine 2011;8(1):255-60.
2010: Yuji Tokuda; Lauren J Carlino; Anuradha Gopalan; SK Tickoo; Matthew G Kaag; Bertrand Guillonneau; James A Eastham; Howard I Scher; Peter T Scardino; Victor E Reuter; Samson W Fine
Prostate cancer topography and patterns of lymph node metastasis.
The American journal of surgical pathology 2010;34(12):1862-7.
2010: Kristen L Zakian; Hedvig Hricak; Nicole Ishill; Victor E Reuter; Steven Eberhardt; Chaya S Moskowitz; Amita Dave; Liang Wang; Peter T Scardino; James A Eastham; Jason A Koutcher
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.
The Journal of urology 2010;184(6):2320-7.
2010: Farhang Rabbani; Jeffrey Schiff; Michael Piecuch; Luis Herran Yunis; James A Eastham; Peter T Scardino; John P Mulhall
Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years?
The journal of sexual medicine 2010;7(12):3984-90.
2010: Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Tim Oliver; Henrik Møller; Victor E Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
Virchows Archiv : an international journal of pathology 2010;457(5):547-53.
2010: Cyrille Bastide; Caroline Savage; Angel Cronin; Michael J Zelefsky; James A Eastham; Karim Touijer; Peter T Scardino; Bertrand Guillonneau
Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.
BJU international 2010;106(10):1454-7.
2010: Christian von Bodman; Mika P Matikainen; Luis Herran Yunis; Vincent Laudone; Peter T Scardino; Oguz Akin; Farhang Rabbani
Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy.
Urology 2010;76(5):1092-6.
2010: Samson W Fine; Anuradha Gopalan; Margaret Leversha; Hikmat Al-Ahmadie; SK Tickoo; Qin Zhou; Jaya M Satagopan; Peter T Scardino; William L Gerald; Victor E Reuter
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(10):1325-33.
2010: Andrew J Vickers; Tineke Wolters; Caroline J Savage; Angel M Cronin; M Frank O'Brien; Monique J Roobol; Gunnar Aus; Peter T Scardino; Jonas Hugosson; Fritz H Schröder; Hans Lilja
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
The Journal of urology 2010;184(3):907-12.
2010: Mika P Matikainen; Christian J von Bodman; Fernando P Secin; Luis Herran Yunis; Kinjal C Vora; Bertrand Guillonneau; Vincent Laudone; James A Eastham; Peter T Scardino; Oguz Akin; Farhang Rabbani
The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy.
BJU international 2010;106(5):622-6.
2010: A Gupta; Monique J Roobol; C J Savage; M Peltola; Kim Pettersson; Peter T Scardino; Andrew J Vickers; Fritz H Schröder; Hans Lilja
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.
British journal of cancer 2010;103(5):708-14.
2010: Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Integrative genomic profiling of human prostate cancer.
Cancer cell 2010;18(1):11-22.
2010: Geoffrey T Gotto; Luis Herran Yunis; Kinjal C Vora; James A Eastham; Peter T Scardino; Farhang Rabbani
Impact of prior prostate radiation on complications after radical prostatectomy.
The Journal of urology 2010;184(1):136-42.
2010: Christian von Bodman; Guilherme Godoy; Daher C Chade; Angel Cronin; Laura J Tafe; Samson W Fine; Vincent Laudone; Peter T Scardino; James A Eastham
Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
The Journal of urology 2010;184(1):143-8.
2010: Scott E Eggener; Georg Salomon; Peter T Scardino; Jean De la Rosette; Thomas J Polascik; Simon Brewster
Focal therapy for prostate cancer: possibilities and limitations.
European urology 2010;58(1):57-64.
2010: Andrew J Vickers; Angel M Cronin; Monique J Roobol; Caroline J Savage; Mari Peltola; Kim Pettersson; Peter T Scardino; Fritz H Schröder; Hans Lilja
A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(12):3232-9.
2010: Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
Cancer 2010;116(11):2612-20.
2010: L Shan; Laurence Ambroisine; Jeremy Clark; Rafael J Yáñez-Muñoz; G Fisher; S C Kudahetti; J Yang; S Kia; X Mao; Anne Fletcher; Penny Flohr; Sandra Edwards; G Attard; Johann S de Bono; Bryan D Young; Christopher S Foster; Victor E Reuter; Henrik Møller; T D Oliver; Daniel M Berney; Peter T Scardino; Jack Cuzick; Colin S Cooper; Yong-Jie Lu
The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.
Prostate cancer and prostatic diseases 2010;13(2):117-25.
2010: Andrew J Vickers; Angel Cronin; Monique Roobol; Caroline Savage; Mari Peltola; Kim Pettersson; Peter T Scardino; Fritz Schröder; Hans Lilja
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(15):2493-8.
2010: David J Gallagher; Joseph Vijai; Angel M Cronin; Jasmine Bhatia; Andrew J Vickers; Mia M. Gaudet; Samson W Fine; Victor E Reuter; Howard I Scher; Christer Halldén; Ana Dutra-Clarke; Robert J. Klein; Peter T Scardino; James A Eastham; Hans Lilja; Tomas Kirchhoff; Kenneth Offit
Susceptibility loci associated with prostate cancer progression and mortality.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2819-32.
2010: Fernando J Bianco; Angel M Cronin; Eric A Klein; J Edson Pontes; Peter T Scardino; Andrew J Vickers
Fellowship training as a modifier of the surgical learning curve.
Academic medicine : journal of the Association of American Medical Colleges 2010;85(5):863-8.
2010: Robert J. Klein; Christer Halldén; Angel M Cronin; Alexander Ploner; Fredrik Wiklund; Anders S Bjartell; Pär Stattin; Jianfeng Xu; Peter T Scardino; Kenneth Offit; Andrew J Vickers; Henrik Grönberg; Hans Lilja
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Cancer prevention research (Philadelphia, Pa.) 2010;3(5):611-9.
2010: David J Gallagher; Mia M. Gaudet; Prodipto Pal; Tomas Kirchhoff; Lisa Balistreri; Kinjal Vora; Jasmine Bhatia; Zsofia Kinga Stadler; Samson W Fine; Victor E Reuter; Michael J Zelefsky; Michael J Morris; Howard I Scher; Robert J. Klein; Larry Norton; James A Eastham; Peter T Scardino; Mark Robson; Kenneth Offit
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(7):2115-21.
2010: William T Lowrance; Elena B Elkin; Lindsay M Jacks; David S Yee; Thomas L Jang; Vincent Laudone; Bertrand D Guillonneau; Peter T Scardino; James A Eastham
Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.
The Journal of urology 2010;183(4):1366-72.
2010: Andrew J Vickers; Fernando Bianco; Angel Cronin; James A Eastham; Eric Klein; Michael Kattan; Peter T Scardino
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.
The Journal of urology 2010;183(4):1360-5.
2010: Michael J Zelefsky; James A Eastham; Angel M Cronin; Zvi Fuks; Zhigang Zhang; Yoshiya Yamada; Andrew J Vickers; Peter T Scardino
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1508-13.
2010: Thomas L Jang; Justin E Bekelman; Yihai Liu; Peter B Bach; Ethan Basch; Elena B Elkin; Michael J Zelefsky; Peter T Scardino; Colin B Begg; Deborah Schrag
Physician visits prior to treatment for clinically localized prostate cancer.
Archives of internal medicine 2010;170(5):440-50.
2010: Peter T Scardino
Robotic prostatectomy: hit or myth?
Nature reviews. Urology 2010;7(3):115.
2010: William T Lowrance; Elena B Elkin; Peter T Scardino; James A Eastham
Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy.
European urology 2010;57(3):538.
2010: Fernando J Bianco; Andrew J Vickers; Angel M Cronin; Eric A Klein; James A Eastham; J Edson Pontes; Peter T Scardino
Variations among experienced surgeons in cancer control after open radical prostatectomy.
The Journal of urology 2010;183(3):977-82.
2010: Farhang Rabbani; Luis Herran Yunis; Rodrigo Pinochet; LUCAS NOGUEIRA; Kinjal C Vora; James A Eastham; Bertrand Guillonneau; Vincent Laudone; Peter T Scardino; Karim Touijer
Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy.
European urology 2010;57(3):371-86.
2010: Andrew J Vickers; Paul Fearn; Peter T Scardino; Mike W Kattan
Why can't nomograms be more like Netflix?
Urology 2010;75(3):511-3.
2010: Oliver Sartor; David G McLeod; Susan Halabi; Paul F Schellhammer; Peter T Scardino; Anthony V D'Amico; Charles Bennett; John T Wei
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer.
Urology 2010;75(3):623-9.
2010: A H M Reid; G Attard; L Ambroisine; G Fisher; G Kovacs; D Brewer; J Clark; P Flohr; S Edwards; D M Berney; C S Foster; A Fletcher; W L Gerald; Henrik Møller; Victor E Reuter; Peter T Scardino; J Cuzick; J S de Bono; C S Cooper
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.
British journal of cancer 2010;102(4):678-84.
2010: Martin K Thomsen; Laurence Ambroisine; Sarah Wynn; Kathryn S E Cheah; Christopher S Foster; Gabrielle Fisher; Daniel M Berney; Henrik Møller; Victor E Reuter; Peter T Scardino; Jack Cuzick; Narasimhan Ragavan; Paras B Singh; Francis L Martin; Christopher M Butler; Colin S Cooper; Amanda Swain
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
Cancer research 2010;70(3):979-87.
2010: Darren Katz; Nelson E Bennett; Jason Stasi; James A Eastham; Bertrand Guillonneau; Peter T Scardino; John P Mulhall
Chronology of erectile function in patients with early functional erections following radical prostatectomy.
The journal of sexual medicine 2010;7(2 Pt 1):803-9.
2010: LUCAS NOGUEIRA; Liang Wang; Samson W Fine; Rodrigo Pinochet; Jordan M Kurta; Darren Katz; Caroline J Savage; Angel M Cronin; Hedvig Hricak; Peter T Scardino; Oguz Akin; Jonathan Coleman
Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.
Urology 2010;75(2):472-7.
2010: Sakunthala C Kudahetti; Gabrielle Fisher; Laurence Ambroisine; David Prowse; Michael W Kattan; Christopher S Foster; Henrik Møller; Tim Oliver; Anne Fletcher; Colin Cooper; Victor E Reuter; Peter T Scardino; Jack Cuzick; Daniel M Berney
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.
Pathology 2010;42(6):519-23.
2010: Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
BMJ (Clinical research ed.) 2010;341():c4521.
2010: Andrew J Vickers; Caroline J Savage; Marwan Shouery; James A Eastham; Peter T Scardino; Ethan Basch
Validation study of a web-based assessment of functional recovery after radical prostatectomy.
Health and quality of life outcomes 2010;8():82.
2010: Christian J Nelson; Serkan Deveci; Jason Stasi; Peter T Scardino; John P Mulhall
Sexual bother following radical prostatectomyjsm.
The journal of sexual medicine 2010;7(1 Pt 1):129-35.
2010: Farhang Rabbani; Ranjith Ramasamy; Manish I Patel; Paul Cozzi; Joseph J Disa; Peter G Cordeiro; Babak J Mehrara; James A Eastham; Peter T Scardino; John P Mulhall
Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy.
The journal of sexual medicine 2010;7(1 Pt 1):166-81.
2009: Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Critical review of prostate cancer predictive tools.
Future oncology (London, England) 2009;5(10):1555-84.
2009: Andrew J Vickers; Angel M Cronin; Michael W Kattan; Mithat Gonen; Peter T Scardino; Matthew I Milowsky; Guido Dalbagni; Bernard H Bochner
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
Cancer 2009;115(23):5460-9.
2009: Andrew J Vickers; Tineke Wolters; Caroline J Savage; Angel M Cronin; M Frank O'Brien; Kim Pettersson; Monique J Roobol; Gunnar Aus; Peter T Scardino; Jonas Hugosson; Fritz H Schröder; Hans Lilja
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.
European urology 2009;56(5):753-60.
2009: Farhang Rabbani; Manish Patel; Paul Cozzi; John P Mulhall; Peter T Scardino
Recovery of erectile function after radical prostatectomy is quantitatively related to the response to intraoperative cavernous nerve stimulation.
BJU international 2009;104(9):1252-7.
2009: Christopher S Foster; Andrew Dodson; L Ambroisine; G Fisher; Henrik Møller; J Clark; G Attard; J De-Bono; Peter T Scardino; Victor E Reuter; Colin S Cooper; D M Berney; Jack Cuzick
Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement.
British journal of cancer 2009;101(7):1137-44.
2009: Andrew J Stephenson; David P Wood Jr; Michael W Kattan; Eric A Klein; Peter T Scardino; James A Eastham; Brett S Carver
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
The Journal of urology 2009;182(4):1357-63.
2009: Chadwick F Haarer; Anuradha Gopalan; SK Tickoo; Peter T Scardino; James A Eastham; Victor E Reuter; Samson W Fine
Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
The Journal of urology 2009;182(4):1337-41.
2009: Farhang Rabbani; Luis Herran Yunis; Kinjal C Vora; James A Eastham; Bertrand Guillonneau; Peter T Scardino; Karim Touijer
Impact of ethnicity on surgical margins at radical prostatectomy.
BJU international 2009;104(7):904-8.
2009: Andrew J Stephenson; Michael W Kattan; James A Eastham; Fernando J Bianco; Ofer Yossepowitch; Andrew J Vickers; Eric A Klein; David P Wood Jr; Peter T Scardino
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4300-5.
2009: Farhang Rabbani; Kinjal C Vora; Luis Herran Yunis; James A Eastham; Bertrand Guillonneau; Peter T Scardino; Karim Touijer
Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
BJU international 2009;104(5):605-10.
2009: Joseph A Pettus; Timothy Masterson; Alexander Sokol; Angel M Cronin; Caroline Savage; Jaspreet S Sandhu; John P Mulhall; Peter T Scardino; Farhang Rabbani
Prostate size is associated with surgical difficulty but not functional outcome at 1 year after radical prostatectomy.
The Journal of urology 2009;182(3):949-55.
2009: Matthew Frank O'Brien; Angel M Cronin; Paul Fearn; Brandon Smith; Jason Stasi; Bertrand Guillonneau; Peter T Scardino; James A Eastham; Andrew J Vickers; Hans Lilja
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3591-7.
2009: Riccardo Valdagni; Peter T Scardino; Louis Denis
The 2008 European School of Oncology inside track conference, "predictive modeling in prostate cancer".
Cancer 2009;115(13 Suppl):3035-8.
2009: Karim Touijer; Peter T Scardino
Nomograms for staging, prognosis, and predicting treatment outcomes.
Cancer 2009;115(13 Suppl):3107-11.
2009: Sak Kudahetti; Gabrielle Fisher; Laurence Ambroisine; Christopher Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; Colin S Cooper; Peter T Scardino; Jack Cuzick; Daniel M Berney
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.
BJU international 2009;104(1):20-4.
2009: Amita Dave; Hedvig Hricak; Nicole Ishill; Chaya S Moskowitz; Marija Drobnjak; Victor E Reuter; Kristen L Zakian; Peter T Scardino; Carlos Cordon-Cardo
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3842-9.
2009: Rile Li; Hong Dai; Thomas M Wheeler; Mohammad Sayeeduddin; Peter T Scardino; Anna Frolov; Gustavo E Ayala
Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3568-73.
2009: Peter T Scardino
Safety in surgery: the checklist.
Nature reviews. Urology 2009;6(5):235.
2009: Brett S Carver; Jennifer Tran; Anuradha Gopalan; Zhenbang Chen; Safa Shaikh; Arkaitz Carracedo; Andrea Alimonti; Caterina Nardella; Shohreh Varmeh; Peter T Scardino; Carlos Cordon-Cardo; William Gerald; Pier Paolo Pandolfi
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.
Nature genetics 2009;41(5):619-24.
2009: David A Bloom; Peter T Scardino
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2.
Urology 2009;73(5):944-6.
2009: David A Bloom; Peter T Scardino
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1.
Urology 2009;73(5):940-3.
2009: Ryan S Brame; Marco Zaider; Kristen L Zakian; Jason A Koutcher; Amita Dave; Victor E Reuter; Michael J Zelefsky; Peter T Scardino; Hedvig Hricak
Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
International journal of radiation oncology, biology, physics 2009;74(1):110-4.
2009: Peter T Scardino
Focal therapy for prostate cancer.
Nature reviews. Urology 2009;6(4):175.
2009: Pauliina Helo; Angel M Cronin; Daniel C Danila; Sven Wenske; Rita Gonzalez-Espinoza; Aseem Anand; Michael Koscuiszka; Riina-Minna Väänänen; Kim Pettersson; Felix K-H Chun; Thomas Steuber; Hartwig Huland; Bertrand D Guillonneau; James A Eastham; Peter T Scardino; Martin Fleisher; Howard I Scher; Hans Lilja
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Clinical chemistry 2009;55(4):765-73.
2009: Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2009;181(4):1635-41; discussion 1641.
2009: D M Berney; A Gopalan; S Kudahetti; G Fisher; L Ambroisine; C S Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; W Gerald; C Cooper; Peter T Scardino; Jack Cuzick
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.
British journal of cancer 2009;100(6):888-93.
2009: R Houston Thompson; James A Eastham; Peter T Scardino; Joel Sheinfeld
Critical elements in fellowship training.
Urologic oncology 2009;27(2):199-204.
2009: Peter T Scardino
Training of a surgeon-scientist.
Urologic oncology 2009;27(2):129.
2009: Amita Dave; Hedvig Hricak; Nicole Ishill; Chaya S Moskowitz; Marija Drobnjak; Victor E Reuter; Kristen L Zakian; Peter T Scardino; Carlos Cordon-Cardo
Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.
Radiology 2009;250(3):803-12.
2009: Michael W Kattan; Andrew J Vickers; Changhong Yu; Fernando J Bianco; Angel M Cronin; James A Eastham; Eric A Klein; Alwyn M Reuther; Jose Edson Pontes; Peter T Scardino
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Cancer 2009;115(5):1005-10.
2009: Philippe Paparel; Oguz Akin; Jaspreet S Sandhu; Javier Romero Otero; Angel M Serio; Peter T Scardino; Hedvig Hricak; Bertrand Guillonneau
Recovery of urinary continence after radical prostatectomy: association with urethral length and urethral fibrosis measured by preoperative and postoperative endorectal magnetic resonance imaging.
European urology 2009;55(3):629-37.
2009: Anuradha Gopalan; Margaret A Leversha; Jaya M Satagopan; Qin Zhou; Hikmat Al-Ahmadie; Samson W Fine; James A Eastham; Peter T Scardino; Howard I Scher; Satish K Tickoo; Victor E Reuter; William L Gerald
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.
Cancer research 2009;69(4):1400-6.
2009: Brett S Carver; Jennifer Tran; Zhenbang Chen; Arkaitz Carracedo-Perez; Andrea Alimonti; Caterina Nardella; Anuradha Gopalan; Peter T Scardino; Carlos Cordon-Cardo; William Gerald; Pier Paolo Pandolfi
ETS rearrangements and prostate cancer initiation.
Nature 2009;457(7231):E1; discussion E2-3.
2009: James A Eastham; Yuji Tokuda; Peter T Scardino
Trends in radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2009;16(2):151-60.
2009: Fernando P Secin; Fernando J Bianco; Angel Cronin; James A Eastham; Peter T Scardino; Bertrand Guillonneau; Andrew J Vickers
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.
The Journal of urology 2009;181(2):609-13; discussion 614.
2009: Sven Wenske; Ruslan Korets; Angel M Cronin; Andrew J Vickers; Martin Fleisher; Howard I Scher; Kim Pettersson; Bertrand Guillonneau; Peter T Scardino; James A Eastham; Hans Lilja
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
International journal of cancer. Journal international du cancer 2009;124(3):659-63.
2009: Riccardo Valdagni; Peter T Scardino; Louis Denis; Michael W Kattan
Predictive modeling in prostate cancer: a conference summary.
European urology 2009;55(2):300-2.
2009: Philippe Paparel; Angel M Cronin; Caroline Savage; Peter T Scardino; James A Eastham
Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
European urology 2009;55(2):404-10.
2009: Scott E Eggener; Andrew J Vickers; Angel M Serio; Michael J Donovan; Faisal M Khan; Valentina Bayer-Zubek; David Verbel; Carlos Cordon-Cardo; Victor E Reuter; Fernando J Bianco; Peter T Scardino
Comparison of models to predict clinical failure after radical prostatectomy.
Cancer 2009;115(2):303-10.
2009: William T Lowrance; Peter T Scardino
Predictive models for newly diagnosed prostate cancer patients.
Reviews in urology 2009;11(3):117-26.
2009: Andrew J Vickers; Peter T Scardino
The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost.
Trials 2009;10():14.
2008: Fritz H Schröder; Mack Roach; Peter T Scardino
Clinical decisions. Management of prostate cancer.
The New England journal of medicine 2008;359(24):2605-9.
2008: Michael Marberger; Peter R Carroll; Michael J Zelefsky; Jonathan Coleman; Hedvig Hricak; Peter T Scardino; Lucien L Abenhaim
New treatments for localized prostate cancer.
Urology 2008;72(6 Suppl):S36-43.
2008: David F Penson; Michel Rossignol; A Oliver Sartor; Peter T Scardino; Lucien L Abenhaim
Prostate cancer: epidemiology and health-related quality of life.
Urology 2008;72(6 Suppl):S3-11.
2008: A Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Jonathan Coleman; David F Penson; Peter R Carroll; Mark A Rubin; Peter T Scardino
Evaluating localized prostate cancer and identifying candidates for focal therapy.
Urology 2008;72(6 Suppl):S12-24.
2008: Peter T Scardino; Lucien L Abenhaim
Focal therapy for prostate cancer: analysis by an international panel.
Urology 2008;72(6 Suppl):S1-2.
2008: Shahrokh F Shariat; Peter T Scardino; Hans Lilja
Screening for prostate cancer: an update.
The Canadian journal of urology 2008;15(6):4363-74.
2008: Edouard J Trabulsi; Richard Valicenti; Alexandra L Hanlon; Thomas M Pisansky; Howard M Sandler; Deborah A Kuban; Charles N Catton; Jeff M Michalski; Michael J Zelefsky; Patrick A Kupelian; Daniel W Lin; Mitchell S Anscher; Kevin Slawin; Claus G Roehrborn; Jeffrey D Forman; Stanley L Liauw; Larry L Kestin; Theodore L DeWeese; Peter T Scardino; Andrew J Stephenson; Alan Pollack
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
Urology 2008;72(6):1298-302; discussion 1302-4.
2008: Joaquin J Garcia; Hikmat Al-Ahmadie; Anuradha Gopalan; SK Tickoo; Peter T Scardino; Victor E Reuter; Samson W Fine
Do prostatic transition zone tumors have a distinct morphology?
The American journal of surgical pathology 2008;32(11):1709-14.
2008: Michael J Donovan; Stefan Hamann; Mark Clayton; Faisal M Khan; Marina Sapir; Valentina Bayer-Zubek; Gerardo Fernandez; Ricardo Mesa-Tejada; Mikhail Teverovskiy; Victor E Reuter; Peter T Scardino; Carlos Cordon-Cardo
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3923-9.
2008: G Attard; J Clark; L Ambroisine; Ian Mills; G Fisher; P Flohr; A Reid; S Edwards; G Kovacs; D Berney; C Foster; C E Massie; A Fletcher; J S De Bono; Peter T Scardino; Jack Cuzick; C S Cooper
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.
British journal of cancer 2008;99(2):314-20.
2008: Andrew J Vickers; Hans Lilja; Peter T Scardino
Five genetic variants associated with prostate cancer.
The New England journal of medicine 2008;358(25):2740; author reply 2741.
2008: Scott A Tomlins; Daniel R Rhodes; Jianjun Yu; Sooryanarayana Lnu; Rohit Mehra; Sven Perner; Francesca Demichelis; Beth E Helgeson; Bharathi Laxman; David S Morris; Qi Cao; Xuhong Cao; Ove Andrén; Katja Fall; Laura Johnson; John T Wei; Rajal B Shah; Hikmat Al-Ahmadie; James A Eastham; Scott E Eggener; Samson W Fine; Kristina Hotakainen; Ulf-Hakan Stenman; Alex Tsodikov; William L Gerald; Hans Lilja; Victor E Reuter; Philip W Kantoff; Peter T Scardino; Mark A Rubin; Anders S Bjartell; Arul M Chinnaiyan
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Cancer cell 2008;13(6):519-28.
2008: Eric A Klein; Fernando J Bianco; Angel M Serio; James A Eastham; Michael W Kattan; J Edson Pontes; Andrew J Vickers; Peter T Scardino
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
The Journal of urology 2008;179(6):2212-6; discussion 2216-7.
2008: James A Eastham; Peter T Scardino; Michael W Kattan
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
The Journal of urology 2008;179(6):2207-10; discussion 2210-1.
2008: John P Mulhall; Alexander Müller; John F Donohue; Dragan Golijanin; Raanan Tal; Yemi Akin-Olugbade; Keith Kobylarz; Leona Cohen-Gould; Nelson E Bennett; Peter T Scardino
FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing.
The journal of sexual medicine 2008;5(6):1334-44.
2008: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2008;179(5 Suppl):S47-51.
2008: Karim Touijer; James A Eastham; Fernando P Secin; Javier Romero Otero; Angel M Serio; Jason Stasi; Rafael Sanchez Salas; Andrew J Vickers; Victor E Reuter; Peter T Scardino; Bertrand Guillonneau
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.
The Journal of urology 2008;179(5):1811-7; discussion 1817.
2008: John P Mulhall; Alexander Müller; John F Donohue; Michael Mullerad; Keith Kobylarz; Darius A Paduch; Raanan Tal; Philip S Li; Leona Cohen-Gould; Peter T Scardino
The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.
The journal of sexual medicine 2008;5(5):1126-36.
2008: Andrew J Vickers; Fernando J Bianco; Mithat Gonen; Angel M Cronin; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
European urology 2008;53(5):960-6.
2008: Ofer Yossepowitch; Scott E Eggener; Angel M Serio; Brett S Carver; Fernando J Bianco; Peter T Scardino; James A Eastham
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.
European urology 2008;53(5):950-9.
2008: Xuesong Ouyang; Walter J Jessen; Hikmat Al-Ahmadie; Angel M Serio; Yong Lin; Weichung-Joseph Shih; Victor E Reuter; Peter T Scardino; Michael M Shen; Bruce Aronow; Andrew J Vickers; William L Gerald; Cory Abate-Shen
Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer.
Cancer research 2008;68(7):2132-44.
2008: Michael J Zelefsky; Victor E Reuter; Zvi Fuks; Peter T Scardino; Alison M Shippy
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.
The Journal of urology 2008;179(4):1368-73; discussion 1373.
2008: Jeremy Clark; Gerhardt Attard; Sameer Jhavar; Penny Flohr; A Reid; Johann S de Bono; Rosalind Eeles; Peter T Scardino; Jack Cuzick; G Fisher; M D Parker; Christopher S Foster; Daniel M Berney; Gyula Kovacs; Colin S Cooper
Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
Oncogene 2008;27(14):1993-2003.
2008: Lee Richstone; Fernando J Bianco; Hiral H Shah; Michael W Kattan; James A Eastham; Peter T Scardino; Douglas Scherr
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU international 2008;101(5):541-6.
2008: Alexander Müller; Raanan Tal; John F Donohue; Yemi Akin-Olugbade; Keith Kobylarz; Darius Paduch; Suzanne C Cutter; Babak J Mehrara; Peter T Scardino; John P Mulhall
The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model.
The journal of sexual medicine 2008;5(3):562-70.
2008: David Ulmert; Angel M Serio; Matthew F O'Brien; Charlotte Becker; James A Eastham; Peter T Scardino; Thomas Björk; Göran Berglund; Andrew J Vickers; Hans Lilja
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):835-41.
2008: Peter T Scardino
Urology: a long history of innovation.
Nature clinical practice. Urology 2008;5(2):59.
2008: Hikmat Al-Ahmadie; SK Tickoo; Semra Olgac; Anuradha Gopalan; Peter T Scardino; Victor E Reuter; Samson W Fine
Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy.
The American journal of surgical pathology 2008;32(2):229-35.
2008: James A Eastham; Michael W Kattan; Paul Fearn; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Jack Cuzick; Peter T Scardino
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
European urology 2008;53(2):347-54.
2008: Gerhardt Attard; Jeremy Clark; L Ambroisine; G Fisher; Gyula Kovacs; Penny Flohr; Daniel M Berney; Christopher S Foster; Anne Fletcher; William L Gerald; Henrik Møller; Victor E Reuter; Johann S de Bono; Peter T Scardino; Jack Cuzick; Colin S Cooper
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
Oncogene 2008;27(3):253-63.
2008: Andrew J Vickers; Angel M Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Becker; Kim Pettersson; Peter T Scardino; Jonas Hugosson; Hans Lilja
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.
BMC medicine 2008;6():19.
2008: David Ulmert; Angel M Cronin; Thomas Björk; Matthew F O'Brien; Peter T Scardino; James A Eastham; Charlotte Becker; Göran Berglund; Andrew J Vickers; Hans Lilja
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
BMC medicine 2008;6():6.
2008: Peter T Scardino
Localized prostate cancer is rarely a fatal disease.
Nature clinical practice. Urology 2008;5(1):1.
2008: Amita Dave; Hedvig Hricak; Peter T Scardino
Imaging low-risk prostate cancer.
Current opinion in urology 2008;18(1):78-86.
2008: Michael W Kattan; Jack Cuzick; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
2007: Xingxing Zang; R Houston Thompson; Hikmat Al-Ahmadie; Angel M Serio; Victor E Reuter; James A Eastham; Peter T Scardino; Padmanee Sharma; James P Allison
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19458-63.
2007: Jason Park; Peter T Scardino
Surgeon's core values: legitimizing the team concept in surgery.
Nature clinical practice. Urology 2007;4(12):635.
2007: Michael W Kattan; Peter T Scardino
Evidence for the usefulness of nomograms.
Nature clinical practice. Urology 2007;4(12):638-9.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
2007: Scott E Eggener; Peter T Scardino; Peter R Carroll; Michael J Zelefsky; Oliver Sartor; Hedvig Hricak; Thomas M Wheeler; Samson W Fine; John Trachtenberg; Mark A Rubin; Mak Ohori; Kentaro Kuroiwa; Michel Rossignol; Lucien Abenhaim
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
The Journal of urology 2007;178(6):2260-7.
2007: Andrew J Vickers; David Ulmert; Angel M Serio; Thomas Björk; Peter T Scardino; James A Eastham; Göran Berglund; Hans Lilja
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
International journal of cancer. Journal international du cancer 2007;121(10):2212-7.
2007: James A Eastham; Kentaro Kuroiwa; Makoto Ohori; Angel M Serio; Alex Gorbonos; Norio Maru; Andrew J Vickers; Kevin Slawin; Thomas M Wheeler; Victor E Reuter; Peter T Scardino
Prognostic significance of location of positive margins in radical prostatectomy specimens.
Urology 2007;70(5):965-9.
2007: Samson W Fine; Hikmat Al-Ahmadie; Anuradha Gopalan; SK Tickoo; Peter T Scardino; Victor E Reuter
Anatomy of the anterior prostate and extraprostatic space: a contemporary surgical pathology analysis.
Advances in anatomic pathology 2007;14(6):401-7.
2007: Thomas L Jang; Ofer Yossepowitch; Fernando J Bianco; Peter T Scardino
Low risk prostate cancer in men under age 65: the case for definitive treatment.
Urologic oncology 2007;25(6):510-4.
2007: Peter T Scardino
Are current staging systems for cancer serving us well?
Nature clinical practice. Urology 2007;4(10):517.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
2007: Rile Li; Sibel Erdamar; Hong Dai; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Timothy C Thompson; Gustavo E Ayala
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Human pathology 2007;38(10):1501-7.
2007: Karim Touijer; Kentaro Kuroiwa; James A Eastham; Andrew J Vickers; Victor E Reuter; Peter T Scardino; Bertrand Guillonneau
Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
European urology 2007;52(4):1090-6.
2007: Junichiro Ishii; Makoto Ohori; Peter T Scardino; Toshiki Tsuboi; Kevin Slawin; Thomas Wheeler
Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens.
International journal of urology : official journal of the Japanese Urological Association 2007;14(9):817-21.
2007: Darko Pucar; Hedvig Hricak; Amita Dave; Kentaro Kuroiwa; Marija Drobnjak; James A Eastham; Peter T Scardino; Michael J Zelefsky
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
International journal of radiation oncology, biology, physics 2007;69(1):62-9.
2007: Michael J Zelefsky; Michael W Kattan; Paul Fearn; Bertha L Fearon; Jason Stasi; Alison M Shippy; Peter T Scardino
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Urology 2007;70(2):283-7.
2007: Peter T Scardino; Alexandra M Hay
Point of care testing: a welcome advance?
Nature clinical practice. Urology 2007;4(8):401.
2007: Andrew J Vickers; Fernando J Bianco; Angel M Serio; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
The surgical learning curve for prostate cancer control after radical prostatectomy.
Journal of the National Cancer Institute 2007;99(15):1171-7.
2007: Ofer Yossepowitch; Scott E Eggener; Fernando J Bianco; Brett S Carver; Angel M Serio; Peter T Scardino; James A Eastham
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
The Journal of urology 2007;178(2):493-9; discussion 499.
2007: Anders Bjartell; Hikmat Al-Ahmadie; Angel M Serio; James A Eastham; Scott E Eggener; Samson W Fine; Lene Udby; William L Gerald; Andrew J Vickers; Hans Lilja; Victor E Reuter; Peter T Scardino
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4130-8.
2007: Peter T Scardino
A hazard surgeons need to address.
Nature clinical practice. Urology 2007;4(7):347.
2007: Carlos Cordon-Cardo; Angeliki Kotsianti; David Verbel; Mikhail Teverovskiy; Paola Capodieci; Stefan Hamann; Yusuf Jeffers; Mark Clayton; Faysal Elkhettabi; Faisal M Khan; Marina Sapir; Valentina Bayer-Zubek; Yevgen Vengrenyuk; Stephen Fogarsi; Olivier Saidi; Victor E Reuter; Howard I Scher; Michael W Kattan; Fernando J Bianco; Thomas M Wheeler; Gustavo E Ayala; Peter T Scardino; Michael J Donovan
Improved prediction of prostate cancer recurrence through systems pathology.
The Journal of clinical investigation 2007;117(7):1876-83.
2007: Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
The Journal of urology 2007;178(1):120-4.
2007: Scott E Eggener; Ofer Yossepowitch; Angel M Serio; Andrew J Vickers; Peter T Scardino; James A Eastham
Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.
Urology 2007;69(6):1128-33.
2007: Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin Slawin; Eric A Klein; Mitchell S. Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard Valicenti; Deborah A Kuban; Alan Pollack
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2035-41.
2007: Peter T Scardino
Intoxicated by technology: are we keeping our eyes on the prize?
Nature clinical practice. Urology 2007;4(5):231.
2007: Peter T Scardino
Prediction models in urology.
Nature clinical practice. Urology 2007;4(4):173.
2007: Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Imaging prostate cancer: a multidisciplinary perspective.
Radiology 2007;243(1):28-53.
2007: William C Huang; Kentaro Kuroiwa; Angel M Serio; Fernando J Bianco; Samson W Fine; Bobby Shayegan; Peter T Scardino; James A Eastham
The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.
The Journal of urology 2007;177(4):1324-9; quiz 1591.
2007: Amita Dave; Hedvig Hricak; Michael W Kattan; Darko Pucar; Kentaro Kuroiwa; Hui-Ni Chen; Jessica Spector; Jason A Koutcher; Kristen L Zakian; Peter T Scardino
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
BJU international 2007;99(4):786-93.
2007: Thomas Steuber; Andrew J Vickers; Alexander Haese; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Ofer Yossepowitch; Fernando J Bianco; Scott E Eggener; James A Eastham; Howard I Scher; Peter T Scardino
The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.
European urology 2007;51(4):940-7; discussion 947-8.
2007: Angelo Baccala; Alwyn M Reuther; Fernando J Bianco; Peter T Scardino; Michael W Kattan; Eric A Klein
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
Urology 2007;69(3):536-40.
2007: Fernando J Bianco; Kozhaya N Mallah; Ruslan Korets; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Urology 2007;69(2):343-6.
2007: Hans Lilja; Andrew J Vickers; Peter T Scardino
Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):347-8.
2007: Fernando P Secin; Theresa Koppie; Peter T Scardino; James A Eastham; Manish Patel; Fernando J Bianco; Raanan Tal; John P Mulhall; Joseph J Disa; Peter G Cordeiro; Farhang Rabbani
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.
The Journal of urology 2007;177(2):664-8.
2007: Thomas Steuber; Andrew J Vickers; Angel M Serio; Ville Vaisanen; Alexander Haese; Kim Pettersson; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Clinical chemistry 2007;53(2):233-40.
2007: Peter T Scardino
The responsible use of antibiotics for an elevated PSA level.
Nature clinical practice. Urology 2007;4(1):1.
2007: Liang Wang; Jingbo Zhang; Lawrence H Schwartz; Halley F Eisenberg; Nicole Ishill; Chaya S Moskowitz; Peter T Scardino; Hedvig Hricak
Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI.
AJR. American journal of roentgenology 2007;188(1):99-104.
2007: Liang Wang; Hedvig Hricak; Michael W Kattan; Hui-Ni Chen; Kentaro Kuroiwa; Halley F Eisenberg; Peter T Scardino
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
Radiology 2007;242(1):182-8.
2006: Theresa Koppie; Fernando J Bianco; Kentaro Kuroiwa; Victor E Reuter; Bertrand Guillonneau; James A Eastham; Peter T Scardino
The clinical features of anterior prostate cancers.
BJU international 2006;98(6):1167-71.
2006: Jack Cuzick; Gabrielle Fisher; Michael W Kattan; Daniel M Berney; T Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.
2006: Charles J Ryan; Alex Smith; Priti Lal; Jaya M Satagopan; Victor E Reuter; Peter T Scardino; William Gerald; Howard I Scher
Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression.
Urology 2006;68(4):834-9.
2006: Bernard H Bochner; Peter T Scardino
Multimodal therapy for urologic cancers.
Nature clinical practice. Urology 2006;3(9):453.
2006: William C Huang; Andrew S Levey; Angel M Serio; Mark Snyder; Andrew J Vickers; Ganesh V Raj; Peter T Scardino; Paul Russo
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.
The lancet oncology 2006;7(9):735-40.
2006: John F Donohue; Fernando J Bianco; Kentaro Kuroiwa; Andrew J Vickers; Thomas M Wheeler; Peter T Scardino; Victor A Reuter; James A Eastham
Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.
The Journal of urology 2006;176(3):991-5.
2006: Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3973-8.
2006: Peter T Scardino
Surgery in elderly cancer patients.
Nature clinical practice. Urology 2006;3(8):397.
2006: William C Huang; Eric O Kwon; Peter T Scardino; James A Eastham
Radical prostatectomy in patients infected with human immunodeficiency virus.
BJU international 2006;98(2):303-7.
2006: Brett S Carver; Fernando J Bianco; Peter T Scardino; James A Eastham
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
The Journal of urology 2006;176(2):564-8.
2006: Julie Solomon; Alexandra M Hay; Peter T Scardino
Peer review: the importance of quality control.
Nature clinical practice. Urology 2006;3(7):345.
2006: Fernando P Secin; Fernando J Bianco; Andrew J Vickers; Victor E Reuter; Thomas Wheeler; Paul Fearn; James A Eastham; Peter T Scardino
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Cancer 2006;106(11):2369-75.
2006: Oguz Akin; Evis Sala; Chaya S Moskowitz; Kentaro Kuroiwa; Nicole Ishill; Darko Pucar; Peter T Scardino; Hedvig Hricak
Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.
Radiology 2006;239(3):784-92.
2006: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul Fearn; Michael W Kattan
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of the National Cancer Institute 2006;98(10):715-7.
2006: Peter T Scardino; Fernando Bianco
The role of outcomes research in improving patient care.
Nature clinical practice. Urology 2006;3(5):233.
2006: Karim Touijer; Kentaro Kuroiwa; Andrew J Vickers; Victor E Reuter; Hedvig Hricak; Peter T Scardino; Bertrand Guillonneau
Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy.
European urology 2006;49(5):853-8.
2006: Ahmad Shabsigh; Peter T Scardino
The urologist and medical imaging.
Nature clinical practice. Urology 2006;3(4):175.
2006: Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.
The Journal of urology 2006;175(4):1320-4; discussion 1324-5.
2006: Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
AJR. American journal of roentgenology 2006;186(3):743-8.
2006: Ernesto Lopez-Corona; Makoto Ohori; Thomas M Wheeler; Victor E Reuter; Peter T Scardino; Michael W Kattan; James A Eastham
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
The Journal of urology 2006;175(3 Pt 1):923-7; discussion 927-8.
2006: Evis Sala; Oguz Akin; Chaya S Moskowitz; Halley F Eisenberg; Kentaro Kuroiwa; Nicole Ishill; Balashanmugam Rajashanker; Peter T Scardino; Hedvig Hricak
Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.
Radiology 2006;238(3):929-37.
2006: Thomas Steuber; Andrew J Vickers; Alexander Haese; Charlotte Becker; Kim Pettersson; Felix K-H Chun; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Peter T Scardino
Supporting the support groups.
Nature clinical practice. Urology 2006;3(2):59.
2006: Rile Li; Thomas M Wheeler; Hong Dai; Mohammad Sayeeduddin; Peter T Scardino; Anna Frolov; Gustavo E Ayala
Biological correlates of p27 compartmental expression in prostate cancer.
The Journal of urology 2006;175(2):528-32.
2006: Andrew J Vickers; Fernando J Bianco; Stephen A Boorjian; Peter T Scardino; James A Eastham
Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?
Cancer 2006;106(3):576-80.
2006: Liang Wang; Hedvig Hricak; Michael W Kattan; Hui-Ni Chen; Peter T Scardino; Kentaro Kuroiwa
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
Radiology 2006;238(2):597-603.
2006: Michael Mullerad; John F Donohue; Philip S Li; Peter T Scardino; John P Mulhall
Functional sequelae of cavernous nerve injury in the rat: is there model dependency.
The journal of sexual medicine 2006;3(1):77-83.
2006: Michael Mullerad; David P Eisenberg; Timothy Akhurst; Prasad S Adusumilli; Christopher C Riedl; Amit Bhargava; Mithat Gonen; Ronald Finn; Peter T Scardino; Yuman Fong
Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):30-5.
2005: Peter T Scardino
Clinical research and the financial markets: opportunities and risks.
Nature clinical practice. Urology 2005;2(12):573.
2005: Toshiki Tsuboi; Makoto Ohori; Kentaro Kuroiwa; Victor E Reuter; Michael W Kattan; James A Eastham; Peter T Scardino
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Urology 2005;66(6):1287-91.
2005: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Michael Mullerad; Hedvig Hricak; Kentaro Kuroiwa; Darko Pucar; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
The Journal of urology 2005;174(6):2158-63.
2005: Alexandra M Hay; Peter T Scardino
Nature Clinical Practice Urology: one year on.
Nature clinical practice. Urology 2005;2(11):517.
2005: Peter T Scardino
Update: NCCN prostate cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3 Suppl 1():S29-33.
2005: Fernando J Bianco; Peter T Scardino; James A Eastham
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").
Urology 2005;66(5 Suppl):83-94.
2005: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Christopher J DiBlasio; Alwyn M Reuther; Eric A Klein; Michael W Kattan
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7005-12.
2005: Stephen A Boorjian; Fernando J Bianco; Peter T Scardino; James A Eastham
Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
BJU international 2005;96(6):773-6.
2005: Peter T Scardino
New technology and the changing world of cancer.
Nature clinical practice. Urology 2005;2(9):403.
2005: Christie Befort; Michael J Zelefsky; Peter T Scardino; Evelinn Borrayo; R Brian Giesler; Michael W Kattan
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
Clinical prostate cancer 2005;4(2):100-8.
2005: Timothy A Masterson; Andrew J Stephenson; Peter T Scardino; James A Eastham
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Urology 2005;66(3):623-6.
2005: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2005;174(3):903-7.
2005: Peter T Scardino
How close are we to preventing prostate cancer?
Nature clinical practice. Urology 2005;2(8):355.
2005: Darko Pucar; Amita Dave; Hedvig Hricak; Chaya S Moskowitz; Kentaro Kuroiwa; Semra Olgac; Lanie E Ebora; Peter T Scardino; Jason A Koutcher; Kristen L Zakian
Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.
Radiology 2005;236(2):545-53.
2005: Andrew J Stephenson; Alex Smith; Michael W Kattan; Jaya M Satagopan; Victor E Reuter; Peter T Scardino; William L Gerald
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Cancer 2005;104(2):290-8.
2005: Heiko Schöder; Ken Herrmann; Mithat Gonen; Hedvig Hricak; Stephen Eberhard; Peter T Scardino; Howard I Scher; Steven M Larson
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4761-9.
2005: Matthew S Kilgo; Michael A Howard; Gordon Kaplan; Farhang Rabbani; Peter T Scardino; Peter G Cordeiro
Evaluation of genitofemoral nerve donor site morbidity after radical prostatectomy.
Annals of plastic surgery 2005;55(1):57-61; discussion 61-2.
2005: Jeffery W Saranchuk; Michael W Kattan; Elena B Elkin; A Karim Touijer; Peter T Scardino; James A Eastham
Achieving optimal outcomes after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4146-51.
2005: Fernando J Bianco; Peter T Scardino; Andrew J Stephenson; Christopher J DiBlasio; Paul Fearn; James A Eastham
Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):448-53.
2005: Fernando J Bianco; Elyn Riedel; Colin B Begg; Michael W Kattan; Peter T Scardino
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.
The Journal of urology 2005;173(6):2099-103.
2005: Pierre I Karakiewicz; Serge Benayoun; Michael W Kattan; Paul Perrotte; Luc Valiquette; Peter T Scardino; Ilias Cagiannos; Hans Heinzer; Simon Tanguay; Armen G Aprikian; Hartwig Huland; Markus Graefen
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Kozhaya N Mallah; Christopher J DiBlasio; Audrey C Rhee; Peter T Scardino; Michael W Kattan
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.
Cancer 2005;103(10):2030-4.
2005: Kathleen Beekman; Michael J Morris; Susan F Slovin; Glenn Heller; Andrew Wilton; Fernando Bianco; Peter T Scardino; Howard I Scher
Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.
Urology 2005;65(5):947-52.
2005: Zohar A Dotan; Fernando J Bianco; Farhang Rabbani; James A Eastham; Paul Fearn; Howard I Scher; Kevin W Kelly; Hui-Ni Chen; Heiko Schöder; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1962-8.
2005: Peter T Scardino; Suzanne J Farley
The physician and conflict of interest.
Nature clinical practice. Urology 2005;2(3):113.
2005: Kristen L Zakian; Kanishka Sircar; Hedvig Hricak; Hui-Ni Chen; Amita Dave; Steven C Eberhardt; Manickam Muruganandham; Lanie Ebora; Michael W Kattan; Victor E Reuter; Peter T Scardino; Jason A Koutcher
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
Radiology 2005;234(3):804-14.
2005: Brett S Carver; Michael W Kattan; Peter T Scardino; James A Eastham
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
BJU international 2005;95(4):509-12.
2005: Brent V Yanke; Mithat Gonen; Peter T Scardino; Michael W Kattan
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
The Journal of urology 2005;173(2):421-4.
2005: Peter T Scardino
Continuing refinements in radical prostatectomy: more evidence that technique matters.
The Journal of urology 2005;173(2):338-9.
2005: Shine Chang; Jr. John W. Erdman; Steven K Clinton; Maya Vadiveloo; Sara S Strom; Yuko Yamamura; Cherie M Duphorne; Margaret R Spitz; Christopher I Amos; John H Contois; Xiangjun Gu; R Joseph Babaian; Peter T Scardino; Stephen D Hursting
Relationship between plasma carotenoids and prostate cancer.
Nutrition and cancer 2005;53(2):127-34.
2005: Peter T Scardino; Paul Fearn
Information systems for urologists: the message from Mansoura, Egypt.
Nature clinical practice. Urology 2005;2(1):1.
2004: Peter T Scardino
Technique matters.
Nature clinical practice. Urology 2004;1(2):55.
2004: Darko Pucar; Jason A Koutcher; Ankoor Shah; Jonathan P Dyke; Lawrence H Schwartz; Howard T Thaler; John Kurhanewicz; Peter T Scardino; W Kevin Kelly; Hedvig Hricak; Kristen L Zakian
Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Clinical prostate cancer 2004;3(3):174-81.
2004: Andrew J Stephenson; Kevin Slawin; Fernando J Bianco; Peter T Scardino
Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy.
BJU international 2004;94(9):1210-2.
2004: Andrew J Stephenson; Peter T Scardino; Fernando J Bianco; Christopher J DiBlasio; Paul Fearn; James A Eastham
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.
The Journal of urology 2004;172(6 Pt 1):2239-43.
2004: Fernando J Bianco; Michael W Kattan; Peter T Scardino
PSA velocity and prostate cancer.
The New England journal of medicine 2004;351(17):1800-2; author reply 1800-2.
2004: Gustavo Ayala; Timothy Thompson; Guang Yang; Anna Frolov; Rile Li; Peter T Scardino; Makoto Ohori; Thomas Wheeler; Wade Harper
High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6572-8.
2004: Andrew J Stephenson; Peter T Scardino; Fernando J Bianco; James A Eastham
Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy.
Current treatment options in oncology 2004;5(5):357-65.
2004: Eiji Kikuchi; Peter T Scardino; Thomas M Wheeler; Kevin Slawin; Makoto Ohori
Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
The Journal of urology 2004;172(2):508-11.
2004: Liang Wang; Michael Mullerad; Hui-Ni Chen; Steven C Eberhardt; Michael W Kattan; Peter T Scardino; Hedvig Hricak
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Radiology 2004;232(1):133-9.
2004: Michael Mullerad; Hedvig Hricak; Liang Wang; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.
Radiology 2004;232(1):140-6.
2004: Hedvig Hricak; Liang Wang; David C Wei; Fergus V Coakley; Oguz Akin; Victor E Reuter; Mithat Gonen; Michael W Kattan; Chinyere N Onyebuchi; Peter T Scardino
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
Cancer 2004;100(12):2655-63.
2004: Amita Dave; Hedvig Hricak; Steven C Eberhardt; Semra Olgac; Manickam Muruganandham; Peter T Scardino; Victor E Reuter; Jason A Koutcher; Kristen L Zakian
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations.
Radiology 2004;231(3):717-24.
2004: Makoto Ohori; Michael W Kattan; Hideshige Koh; Norio Maru; Kevin Slawin; Shahrokh F Shariat; Masatoshi Muramoto; Victor E Reuter; Thomas M Wheeler; Peter T Scardino
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
2004: Tamar Sella; Lawrence H Schwartz; Peter W Swindle; Chinyere N Onyebuchi; Peter T Scardino; Howard I Scher; Hedvig Hricak
Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging.
Radiology 2004;231(2):379-85.
2004: Manish I Patel; Dino T DeConcini; Ernesto Lopez-Corona; Makoto Ohori; Thomas Wheeler; Peter T Scardino
An analysis of men with clinically localized prostate cancer who deferred definitive therapy.
The Journal of urology 2004;171(4):1520-4.
2004: Andrew J Stephenson; Shahrokh F Shariat; Michael J Zelefsky; Michael W Kattan; E. Brian Butler; Bin S Teh; Eric A Klein; Patrick A Kupelian; Claus G Roehrborn; David A Pistenmaa; Heather D Pacholke; Stanley L Liauw; Matthew Katz; Steven A Leibel; Peter T Scardino; Kevin Slawin
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
2004: Makoto Ohori; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Radical prostatectomy for carcinoma of the prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):349-59.
2004: Rile Li; Mamoun Younes; Thomas M Wheeler; Peter T Scardino; Makoto Ohori; Anna Frolov; Gustavo Ayala
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
The Prostate 2004;58(2):193-9.
2004: RE Hall; David J Horsfall; Jürgen Stahl; Suchindra Vivekanandan; Carmela Ricciardelli; A M F Stapleton; Peter T Scardino; Petra Neufing; Wayne D Tilley
Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
The Prostate 2004;58(2):103-8.
2004: Badrinath R Konety; James A Eastham; Victor E Reuter; Peter T Scardino; S Machele Donat; Guido Dalbagni; Paul Russo; Harry W Herr; Lawrence H Schwartz; Philip W Kantoff; Howard I Scher; W Kevin Kelly
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
The Journal of urology 2004;171(2 Pt 1):709-13.
2004: Ilias Cagiannos; Pierre I Karakiewicz; Markus Graefen; James A Eastham; Makoto Ohori; Farhang Rabbani; Victor E Reuter; Thomas Wheeler; Patrick A Kupelian; Eric Klein; Hartwig Huland; Peter Hammerer; Andreas Erbersdobler; Fritz Schroeder; Mark F Wildhagen; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Jeff Holzbeierlein; Priti Lal; Eva LaTulippe; Alex Smith; Jaya M Satagopan; Liying Zhang; Charles Ryan; Steve Smith; Howard I Scher; Peter T Scardino; Victor E Reuter; William L Gerald
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.
The American journal of pathology 2004;164(1):217-27.
2004: Markus Graefen; Makoto Ohori; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Rolf-Peter Henke; Hartwig Huland; Thomas M Wheeler; Kevin Slawin; Peter T Scardino; Michael W Kattan
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2003: Michael W Kattan; Michael J Zelefsky; Patrick A Kupelian; Daniel Cho; Peter T Scardino; Zvi Fuks; Steven A Leibel
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4568-71.
2003: James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor E Reuter; Peter T Scardino
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2003;170(6 Pt 1):2292-5.
2003: Ilias Cagiannos; Pierre I Karakiewicz; James A Eastham; Makoto Ohori; Farhang Rabbani; Claudia Gerigk; Victor E Reuter; Markus Graefen; Peter Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick A Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Michael W Kattan; James A Eastham; Thomas M Wheeler; Norio Maru; Peter T Scardino; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Hideshige Koh; Shahrokh F Shariat; Kevin Slawin; Makoto Ohori
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Gustavo Ayala; Jennifer A Tuxhorn; Thomas M Wheeler; Anna Frolov; Peter T Scardino; Makoto Ohori; Marcus Wheeler; Jeffrey Spitler; David R Rowley
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):4792-801.
2003: Michael W Kattan; Peter T Scardino
Prostate cancer: nomograms and risk assessment models.
Journal of the National Comprehensive Cancer Network : JNCCN 2003;1 Suppl 3():S-49-54.
2003: Christopher J Di Blasio; Audrey C Rhee; Daniel Cho; Peter T Scardino; Michael W Kattan
Predicting clinical end points: treatment nomograms in prostate cancer.
Seminars in oncology 2003;30(5):567-86.
2003: Hideshige Koh; Michael W Kattan; Peter T Scardino; Kazuho Suyama; Norio Maru; Kevin Slawin; Thomas M Wheeler; Makoto Ohori
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.
The Journal of urology 2003;170(4 Pt 1):1203-8.
2003: Ernesto Lopez-Corona; Makoto Ohori; Peter T Scardino; Victor E Reuter; Mithat Gonen; Michael W Kattan
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.
The Journal of urology 2003;170(4 Pt 1):1184-8; discussion 1188.
2003: Pascal Eschwège; Sophie Ferlicot; Stéphane Droupy; Nathalie Ba; M Conti; Sylvain Loric; G Coindard; I Denis; L Ferretti; A Cornelius; A Legrand; Pierre Bedossa; Gérard Benoît; Alain Jardin; Peter T Scardino
A histopathologic investigation of PGE(2) pathways as predictors of proliferation and invasion in urothelial carcinomas of the bladder.
European urology 2003;44(4):435-41.
2003: Kristen L Zakian; Steven C Eberhardt; Hedvig Hricak; Amita Dave; Shanon Kleinman; Manickam Muruganandham; Kanishka Sircar; Michael W Kattan; Victor E Reuter; Peter T Scardino; Jason A Koutcher
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Radiology 2003;229(1):241-7.
2003: Michael W Kattan; Shahrokh F Shariat; Ben Andrews; Kuichun Zhu; Eduardo I Canto; Kazumasa Matsumoto; Masatoshi Muramoto; Peter T Scardino; Makoto Ohori; Thomas M Wheeler; Kevin Slawin
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
2003: Shahrokh F Shariat; Martine P Roudier; George E Wilcox; Michael W Kattan; Peter T Scardino; Robert L Vessella; Sibel Erdamar; Cuong Nguyen; Thomas M Wheeler; Kevin Slawin
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
2003: Peter T Scardino
The prevention of prostate cancer--the dilemma continues.
The New England journal of medicine 2003;349(3):297-9.
2003: Rile Li; Mamoun Younes; Anna Frolov; Thomas M Wheeler; Peter T Scardino; Makoto Ohori; Gustavo Ayala
Expression of neutral amino acid transporter ASCT2 in human prostate.
Anticancer research 2003;23(4):3413-8.
2003: Michael Aleman; Pierre I Karakiewicz; Patrick A Kupelian; Michael W Kattan; Markus Graefen; Ilias Cagiannos; James A Eastham; Peter T Scardino; Hartwig Huland; Eric A Klein
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Fernando J Bianco; Michael W Kattan; Peter T Scardino; Isaac J Powell; J Edson Pontes; David P Wood Jr
Radical prostatectomy nomograms in black American men: accuracy and applicability.
The Journal of urology 2003;170(1):73-6; discussion 76-7.
2003: Ofer Yossepowitch; Edouard J Trabulsi; Michael W Kattan; Peter T Scardino
Predictive factors in prostate cancer: implications for decision making.
Cancer investigation 2003;21(3):465-80.
2003: James A Eastham; Christopher J DiBlasio; Peter T Scardino
Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy.
Current urology reports 2003;4(3):211-5.
2003: James A Eastham; Elyn Riedel; Peter T Scardino; Moshe Shike; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Lianne Latkany; Colin B Begg
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
JAMA : the journal of the American Medical Association 2003;289(20):2695-700.
2003: Markus Graefen; Herbert Augustin; P I Karakiewicz; Peter Hammerer; Alexander Haese; Jüri Palisaar; S Fernandez; Joachim Noldus; Andreas Erbersdobler; Ilias Cagiannos; Peter T Scardino; Michael W Kattan; Hartwig Huland
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy].
Der Urologe. Ausg. A 2003;42(5):685-92.
2003: Peter W Swindle; Michael W Kattan; Peter T Scardino
Markers and meaning of primary treatment failure.
The Urologic clinics of North America 2003;30(2):377-401.
2003: Shahrokh F Shariat; Michael W Kattan; Sibel Erdamar; Cuong Nguyen; Peter T Scardino; David M Spencer; Thomas M Wheeler; Kevin Slawin
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
2003: Makoto Ohori; Michael W Kattan; Takuji Utsunomiya; Kazuho Suyama; Peter T Scardino; Thomas M Wheeler
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?
The Journal of urology 2003;169(3):964-8.
2003: Alexander Haese; Markus Graefen; Charlotte Becker; Joachim Noldus; Jared Katz; Ilias Cagiannos; Michael W Kattan; Peter T Scardino; Edith Huland; Hartwig Huland; Hans Lilja
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
2003: Douglas Scherr; Peter W Swindle; Peter T Scardino
National Comprehensive Cancer Network guidelines for the management of prostate cancer.
Urology 2003;61(2 Suppl 1):14-24.
2003: Pierre I Karakiewicz; Michael W Kattan; Simon Tanguay; Mostafa Elhilali; Michel Bazinet; Peter T Scardino; Armen G Aprikian
Cross-cultural validation of the UCLA prostate cancer index.
Urology 2003;61(2):302-7.
2003: Colin B Begg; Peter T Scardino
Taking stock of volume-outcome studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):393-4.
2003: Phillip L Ross; Benjamin Littenberg; Paul Fearn; Peter T Scardino; Pierre I Karakiewicz; Michael W Kattan
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
International journal of technology assessment in health care 2003;19(1):135-47.
2002: Frank A Vicini; Alvaro Martinez; Gerald Hanks; Alexandra Hanlon; Brian Miles; Ken Kernan; David Beyers; Haakon Ragde; Jeffrey D Forman; James Fontanesi; Larry L Kestin; Gyorgy Kovacs; Louis Denis; Kevin Slawin; Peter T Scardino
An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up.
Cancer 2002;95(10):2126-35.
2002: Ofer Yossepowitch; Kanishka Sircar; Peter T Scardino; Makoto Ohori; Michael W Kattan; Thomas M Wheeler; Victor E Reuter
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
The Journal of urology 2002;168(5):2011-5.
2002: Paul J Cozzi; Peter B Burke; Amit Bhargav; Warren D W Heston; Bob Huryk; Peter T Scardino; Yuman Fong
Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses.
The Prostate 2002;53(2):95-100.
2002: Michael W Kattan; Peter T Scardino
Prediction of progression: nomograms of clinical utility.
Clinical prostate cancer 2002;1(2):90-6.
2002: Makoto Ohori; Peter T Scardino
Localized prostate cancer.
Current problems in surgery 2002;39(9):833-957.
2002: Fergus V Coakley; Steven C Eberhardt; Michael W Kattan; David C Wei; Peter T Scardino; Hedvig Hricak
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.
The Journal of urology 2002;168(3):1032-5.
2002: Eva LaTulippe; Jaya M Satagopan; Alex Smith; Howard I Scher; Peter T Scardino; Victor E Reuter; William L Gerald
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.
Cancer research 2002;62(15):4499-506.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick A Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard H Bochner; Hartwig Huland; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo Van der Kwast; Peter T Scardino; Michael W Kattan
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Salvador Fernandez; Jochen Noldus; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Hideshige Koh; Norio Maru; Masatoshi Muramoto; Thomas M Wheeler; Peter T Scardino; Makoto Ohori
[The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology 2002;93(5):595-601.
2002: Fergus V Coakley; Steven C Eberhardt; David C Wei; Evan S Wasserman; Stefan B J Heinze; Peter T Scardino; Hedvig Hricak
Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging.
Urology 2002;59(6):884-8.
2002: James A Eastham; Michael W Kattan; Peter T Scardino
Nomograms as predictive models.
Seminars in urologic oncology 2002;20(2):108-15.
2002: Phillip L Ross; Claudia Gerigk; Mithat Gonen; Ofer Yossepowitch; Ilias Cagiannos; Pramod C Sogani; Peter T Scardino; Michael W Kattan
Comparisons of nomograms and urologists' predictions in prostate cancer.
Seminars in urologic oncology 2002;20(2):82-8.
2002: Ilias Cagiannos; Markus Graefen; Pierre I Karakiewicz; Makoto Ohori; James A Eastham; Farhang Rabbani; William Fair; Thomas M Wheeler; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Colin B Begg; Elyn Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino
Variations in morbidity after radical prostatectomy.
The New England journal of medicine 2002;346(15):1138-44.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Peter Hammerer; Alexander Haese; Jüri Palisaar; Edith Huland; Peter T Scardino; Michael W Kattan; Hartwig Huland
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Eric Klein; Patrick A Kupelian; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Peter T Scardino; Michael W Kattan
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
2002: Joyce A O'Shaughnessy; Gary J Kelloff; Gary B Gordon; Andrew J Dannenberg; Waun Ki Hong; Carol J Fabian; Caroline C Sigman; Monica M Bertagnolli; Steven P Stratton; Stephen Lam; William G Nelson; Frank L Meyskens; David S Alberts; Michele Follen; Anil K Rustgi; Vassiliki A Papadimitrakopoulou; Peter T Scardino; Adi F Gazdar; Lee W Wattenberg; Michael B. Sporn; Wael A Sakr; Scott M Lippman; Daniel Von Hoff
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):314-46.
2002: Douglas Scherr; James A Eastham; Makoto Ohori; Peter T Scardino
Prostate biopsy techniques and indications: when, where, and how?
Seminars in urologic oncology 2002;20(1):18-31.
2002: Jerry Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.
The Journal of urology 2002;167(2 Pt 1):528-34.
2001: Edward D Kim; R Nath; Kevin Slawin; Dov Kadmon; B J Miles; Peter T Scardino
Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up.
Urology 2001;58(6):983-7.
2001: P S Kothari; Peter T Scardino; Makoto Ohori; Michael W Kattan; Thomas M Wheeler
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
The American journal of surgical pathology 2001;25(11):1429-32.
2001: Alla Turlakow; Steven M Larson; F Coakley; Timothy Akhurst; Mithat Gonen; Homer A Macapinlac; W Kelly; Steven Leibel; John L Humm; Peter T Scardino; Howard I Scher; Hedvig Hricak
Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(3):235-44.
2001: James A Eastham; Peter T Scardino
Early diagnosis and treatment of prostate cancer.
Disease-a-month : DM 2001;47(9):421-59.
2001: Michael W Kattan; Louis Potters; John C Blasko; David C Beyer; Paul Fearn; William Cavanagh; Steven Leibel; Peter T Scardino
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.
Urology 2001;58(3):393-9.
2001: Norio Maru; Makoto Ohori; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Human pathology 2001;32(8):828-33.
2001: Sara S Strom; Margaret R Spitz; Yuko Yamamura; R Joseph Babaian; Peter T Scardino; Qingyi Wei
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control study.
The Prostate 2001;47(4):269-75.
2001: Peter T Scardino; E D Kim
Rationale for and results of nerve grafting during radical prostatectomy.
Urology 2001;57(6):1016-9.
2001: Edward D Kim; R Nath; Dov Kadmon; Larry I Lipshultz; Brian J Miles; Kevin Slawin; Hsiao-Yuan Tang; Thomas Wheeler; Peter T Scardino
Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup.
The Journal of urology 2001;165(6 Pt 1):1950-6.
2001: P J Cozzi; Sandeep Malhotra; Priscilla F McAuliffe; David A Kooby; Howard Federoff; B Huryk; P Johnson; Peter T Scardino; Warren D W Heston; Yuman Fong
Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(7):1306-8.
2001: Phillip L Ross; Peter T Scardino; Michael W Kattan
A catalog of prostate cancer nomograms.
The Journal of urology 2001;165(5):1562-8.
2001: C M Herman; Michael W Kattan; Makoto Ohori; Peter T Scardino; Thomas M Wheeler
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy.
The American journal of surgical pathology 2001;25(5):657-60.
2001: Cheryl T Lee; Peter T Scardino
Percent free prostate-specific antigen for first-time prostate biopsy.
Urology 2001;57(4):594-8.
2001: Edward D Kim; Peter T Scardino; Dov Kadmon; Kevin Slawin; Rahul K Nath
Interposition sural nerve grafting during radical retropubic prostatectomy.
Urology 2001;57(2):211-6.
2001: Shine Chang; Stephen D Hursting; John H Contois; Sara S Strom; Yuko Yamamura; R Joseph Babaian; Patricia Troncoso; Peter T Scardino; T M Wheeler; Christopher I Amos; Margaret R Spitz
Leptin and prostate cancer.
The Prostate 2001;46(1):62-7.
2000: Farhang Rabbani; A M Stapleton; Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Factors predicting recovery of erections after radical prostatectomy.
The Journal of urology 2000;164(6):1929-34.
2000: Robert R Bahnson; G E Hanks; R P Huben; Philip W Kantoff; J M Kozlowski; Michael Kuettel; P H Lange; C Logothetis; Julio Pow-Sang; M Roach; Howard Sandler; Peter T Scardino; R J Taylor; Donald A Urban; Patrick C Walsh; T G Wilson
NCCN Practice Guidelines for Prostate Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):111-9.
2000: Michael L Blute; E J Bergstralh; Alan W Partin; Patrick C Walsh; Michael W Kattan; Peter T Scardino; James E Montie; Jay D Pearson; J M Slezak; Horst Zincke
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Michael W Kattan; Michael J Zelefsky; Patrick A Kupelian; Peter T Scardino; Zvi Fuks; Steven A Leibel
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3352-9.
2000: William J Catalona; PC Southwick; Kevin Slawin; Alan W Partin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Patrick C Walsh; Peter T Scardino; PH Lange; GH Gasior; KG Loveland; KR Bray
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.
Urology 2000;56(2):255-60.
2000: Carlos A Perez; David C Beyer; John C Blasko; JD Forman; DH Hussey; W Robert Lee; SB Paryani; Alan Pollack; Louis Potters; Mack Roach; Peter T Scardino; P Schellhammer; Steven Leibel
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1449-72.
2000: Mack Roach; John C Blasko; Carlos A Perez; David C Beyer; JD Forman; DH Hussey; W Robert Lee; SB Paryani; Alan Pollack; Louis Potters; Peter T Scardino; P Schellhammer; Steven Leibel
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1441-8.
2000: Carlos A Perez; David C Beyer; John C Blasko; JD Forman; DH Hussey; W Robert Lee; SB Paryani; Alan Pollack; Louis Potters; Mack Roach; Peter T Scardino; P Schellhammer; Steven Leibel
Postradical prostatectomy irradiation in carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1419-39.
2000: W Robert Lee; Alan Pollack; Carlos A Perez; David C Beyer; John C Blasko; JD Forman; DH Hussey; SB Paryani; Louis Potters; Mack Roach; Peter T Scardino; P Schellhammer; Steven Leibel
Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1413-8.
2000: Alan Pollack; SB Paryani; D Hussey; Carlos A Perez; David C Beyer; John C Blasko; JD Forman; W Robert Lee; Louis Potters; Mack Roach; Peter T Scardino; P Schellhammer; Steven Leibel
Locally advanced (high-risk) prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1401-12.
2000: Louis Potters; Carlos A Perez; David C Beyer; John C Blasko; JD Forman; DH Hussey; W Robert Lee; SB Paryani; Alan Pollack; Mack Roach; Peter T Scardino; P Schellhammer; Steven Leibel
Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1383-400.
2000: JD Forman; W Robert Lee; Mack Roach; Carlos A Perez; David C Beyer; John C Blasko; DH Hussey; SB Paryani; Alan Pollack; Louis Potters; Peter T Scardino; P Schellhammer; Steven Leibel
Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000;215 Suppl():1373-82.
2000: C M Herman; G E Wilcox; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
Lymphovascular invasion as a predictor of disease progression in prostate cancer.
The American journal of surgical pathology 2000;24(6):859-63.
2000: Moshe Shalev; Dov Kadmon; Bin S Teh; E. Brian Butler; Estuardo Aguilar-Cordova; Timothy C Thompson; JR Herman; HL Adler; Peter T Scardino; Brian J Miles
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
The Journal of urology 2000;163(6):1747-50.
2000: Margaret R Spitz; S S Strom; Y Yamamura; P Troncoso; R J Babaian; Peter T Scardino; T Wheeler; Christopher I Amos; A von Eschenbach; J Kagan
Epidemiologic determinants of clinically relevant prostate cancer.
International journal of cancer. Journal international du cancer 2000;89(3):259-64.
2000: William J Catalona; Alan W Partin; Kevin Slawin; C K Naughton; Michael K Brawer; RC Flanigan; JP Richie; A Patel; Patrick C Walsh; Peter T Scardino; PH Lange; Jean B deKernion; PC Southwick; KG Loveland; RE Parson; GH Gasior
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
Urology 2000;55(3):372-6.
2000: Peter T Scardino
The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.
Transactions of the American Clinical and Climatological Association 2000;111():201-41.
1999: Rabih O Darouiche; J A Smith; H Hanna; Chirpriya B Dhabuwala; M S Steiner; R J Babaian; Timothy B Boone; Peter T Scardino; John Thornby; Issam I Raad
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial.
Urology 1999;54(6):976-81.
1999: B H Lowentritt; Peter T Scardino; Brian J Miles; FJ Orejuela; EC Schatte; Kevin Slawin; S P Elliott; Edward D Kim
Sildenafil citrate after radical retropubic prostatectomy.
The Journal of urology 1999;162(5):1614-7.
1999: G C Williams; Andrew G Lee; H L Adler; A Coburn; A L Rosas; Rosa A Tang; Peter T Scardino
Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy.
The Journal of urology 1999;162(4):1384-5.
1999: PC Southwick; William J Catalona; Alan W Partin; Kevin Slawin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Patrick C Walsh; Peter T Scardino; PH Lange; GH Gasior; RE Parson; KG Loveland
Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
The Journal of urology 1999;162(4):1346-51.
1999: R K Mootha; R Butler; Rodolfo Laucirica; Peter T Scardino; Seth P Lerner
Renal cell carcinoma with an infrarenal vena caval tumor thrombus.
Urology 1999;54(3):561.
1999: Nicholas J Hegarty; John M Fitzpatrick; J P Richie; Peter T Scardino; Ralph W deVere White; F H Schröder; Donald S Coffey
Future prospects in prostate cancer.
The Prostate 1999;40(4):261-8.
1999: JR Herman; HL Adler; Estuardo Aguilar-Cordova; A Rojas-Martinez; Shiao Woo; Terry L Timme; Thomas M Wheeler; Timothy C Thompson; Peter T Scardino
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.
Human gene therapy 1999;10(7):1239-49.
1999: Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1499-507.
1999: D J Tindall; Peter T Scardino
Defeating prostate cancer: crucial directions for research--excerpt from the report of the Prostate Cancer Progress Review Group.
The Prostate 1999;38(2):166-71.
1999: Makoto Ohori; F Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino; Seth P Lerner
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.
The Journal of urology 1999;161(2):500-4.
1999: Edward D Kim; Peter T Scardino; Ori Hampel; N L Mills; Thomas M Wheeler; Rahul K Nath
Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy.
The Journal of urology 1999;161(1):188-92.
1999: HL Adler; MA McCurdy; Michael W Kattan; Terry L Timme; Peter T Scardino; Timothy C Thompson
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
The Journal of urology 1999;161(1):182-7.
1998: J C Hu; GS Palapattu; Michael W Kattan; Peter T Scardino; Thomas M Wheeler
The association of selected pathological features with prostate cancer in a single-needle biopsy accession.
Human pathology 1998;29(12):1536-8.
1998: G Wilcox; Shigehiro Soh; S Chakraborty; Peter T Scardino; Thomas M Wheeler
Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer.
Human pathology 1998;29(10):1119-23.
1998: Guang Yang; Luan D Truong; Terry L Timme; Chengzhen Ren; Thomas M Wheeler; Sang Hee Park; Yasutomo Nasu; CH Bangma; Michael W Kattan; Peter T Scardino; Timothy C Thompson
Elevated expression of caveolin is associated with prostate and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1873-80.
1998: Thomas M Wheeler; O Dillioglugil; Michael W Kattan; A Arakawa; Shigehiro Soh; K Suyama; Makoto Ohori; Peter T Scardino
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
Human pathology 1998;29(8):856-62.
1998: Y Goto; M Ohori; Peter T Scardino
Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report.
International journal of urology : official journal of the Japanese Urological Association 1998;5(4):337-42.
1998: BD Leibman; O Dillioglugil; F Abbas; S Tanli; Michael W Kattan; Peter T Scardino
Impact of a clinical pathway for radical retropubic prostatectomy.
Urology 1998;52(1):94-9.
1998: BD Leibman; O Dillioglugil; Peter T Scardino; F Abbas; E Rogers; R D Wolfinger; Michael W Kattan
Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2267-71.
1998: William J Catalona; Alan W Partin; Kevin Slawin; Michael K Brawer; RC Flanigan; A Patel; JP Richie; Jean B deKernion; Patrick C Walsh; Peter T Scardino; PH Lange; EN Subong; RE Parson; GH Gasior; KG Loveland; PC Southwick
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.
JAMA : the journal of the American Medical Association 1998;279(19):1542-7.
1998: Michael W Kattan; James A Eastham; A M Stapleton; T M Wheeler; Peter T Scardino
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
Journal of the National Cancer Institute 1998;90(10):766-71.
1998: A M Stapleton; P Zbell; Michael W Kattan; Guang Yang; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Cancer 1998;82(1):168-75.
1997: E. Brian Butler; Peter T Scardino; Bin S Teh; Barry M Uhl; W G Guerriero; C E Carlton; B M Berner; WS Dennis; L Steven Carpenter; Hsin H Lu; J Kam Chiu; T S Kent; Shiao Y Woo
The Baylor College of Medicine experience with gold seed implantation.
Seminars in surgical oncology 1997;13(6):406-18.
1997: James A Eastham; Michael W Kattan; S Groshen; Peter T Scardino; E Rogers; C E Carlton; Seth P Lerner
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3214-22.
1997: F Abbas; Peter T Scardino
The natural history of clinical prostate carcinoma.
Cancer 1997;80(5):827-33.
1997: Martin I Resnick; J A Smith; Peter T Scardino; M J Egger; A Hernandez; S C Rose
Transrectal prostate ultrasonography: variability of interpretation.
The Journal of urology 1997;158(3 Pt 1):856-60.
1997: A M Stapleton; Terry L Timme; Angelo E Gousse; Q F Li; A A Tobon; Michael W Kattan; Kevin Slawin; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1389-97.
1997: O Dillioglugil; BD Leibman; Michael W Kattan; C Seale-Hawkins; Thomas M Wheeler; Peter T Scardino
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.
Urology 1997;50(1):93-9.
1997: Shigehiro Soh; Michael W Kattan; S Berkman; Thomas M Wheeler; Peter T Scardino
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?
The Journal of urology 1997;157(6):2212-8.
1997: Alan W Partin; Michael W Kattan; EN Subong; Patrick C Walsh; Kirk J Wojno; JE Oesterling; Peter T Scardino; Jay D Pearson
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: O Dillioglugil; BD Leibman; N S Leibman; Michael W Kattan; A L Rosas; Peter T Scardino
Risk factors for complications and morbidity after radical retropubic prostatectomy.
The Journal of urology 1997;157(5):1760-7.
1997: Paul F Schellhammer; A Cockett; L Boccon-Gibod; M Gospodarowicz; A Krongrad; Ian M Thompson; Peter T Scardino; Mark S Soloway; J Adolfsson
Assessment of endpoints for clinical trials for localized prostate cancer.
Urology 1997;49(4A Suppl):27-38.
1997: Peter T Scardino; G E Hanks
A comparison of prostate cancer treatments: are therapeutic implications justified?
The cancer journal from Scientific American 1997;3(2):70-2.
1997: Joseph A Smith; Peter T Scardino; M I Resnick; A D Hernandez; S C Rose; M J Egger
Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial.
The Journal of urology 1997;157(3):902-6.
1997: Michael W Kattan; A M Stapleton; Thomas M Wheeler; Peter T Scardino
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma.
Cancer 1997;79(3):528-37.
1997: Glenn S Gerber; Ronald A Thisted; Gerald Chodak; F H Schroder; H G Frohmuller; Peter T Scardino; D F Paulson; A W Middleton; DB Rukstalis; J A Smith; M Ohori; M Theiss; P F Schellhammer
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis.
European urology 1997;32(4):385-90.
1996: F Abbas; Peter T Scardino
Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary.
The Urologic clinics of North America 1996;23(4):587-604.
1996: James A Eastham; Michael W Kattan; E Rogers; J R Goad; Makoto Ohori; Timothy B Boone; Peter T Scardino
Risk factors for urinary incontinence after radical prostatectomy.
The Journal of urology 1996;156(5):1707-13.
1996: Guang Yang; Thomas M Wheeler; Michael W Kattan; Peter T Scardino; Timothy C Thompson
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
Cancer 1996;78(6):1267-71.
1996: E Rogers; T Gürpinar; O Dillioglugil; Michael W Kattan; J R Goad; Peter T Scardino; D P Griffith
The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
British journal of urology 1996;78(3):419-25.
1996: Y Goto; Makoto Ohori; A Arakawa; Michael W Kattan; Thomas M Wheeler; Peter T Scardino
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.
The Journal of urology 1996;156(3):1059-63.
1996: G E Hanks; Peter T Scardino
Does screening for prostate cancer make sense?
Scientific American 1996;275(3):114-5.
1996: Glenn S Gerber; Ronald A Thisted; Peter T Scardino; H G Frohmuller; F H Schroeder; D F Paulson; A W Middleton; DB Rukstalis; J A Smith; P F Schellhammer; M Ohori; Gerald Chodak
Results of radical prostatectomy in men with clinically localized prostate cancer.
JAMA : the journal of the American Medical Association 1996;276(8):615-9.
1996: David G Bostwick; T M Wheeler; Michael L Blute; D M Barrett; G T MacLennan; Thomas J Sebo; Peter T Scardino; P A Humphrey; M A Hudson; Y Fradet; G J Miller; E D Crawford; Brent Blumenstein; H E Mahran; B J Miles
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.
Urology 1996;48(1):47-57.
1996: R H Williams; A M Stapleton; Guang Yang; Luan D Truong; E Rogers; Terry L Timme; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(4):635-40.
1996: E Rogers; James A Eastham; Makoto Ohori; O Sariyuce; M Aihara; Thomas M Wheeler; Peter T Scardino
Impalpable prostate cancer: clinicopathological features.
British journal of urology 1996;77(3):429-32.
1996: Guang Yang; A M Stapleton; Thomas M Wheeler; Luan D Truong; Terry L Timme; Peter T Scardino; Timothy C Thompson
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):399-401.
1995: BD Leibman; O Dillioglugil; Thomas M Wheeler; Peter T Scardino
Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen level.
Cancer 1995;76(12):2530-4.
1995: J R Goad; James A Eastham; K B Fitzgerald; Michael W Kattan; M P Collini; D H Yawn; Peter T Scardino
Radical retropubic prostatectomy: limited benefit of autologous blood donation.
The Journal of urology 1995;154(6):2103-9.
1995: B J Miles; Peter T Scardino; Mark E Cowen; C McAuley
A 72-year-old man with localized prostate cancer.
JAMA : the journal of the American Medical Association 1995;274(18):1426-7.
1995: Makoto Ohori; Thomas M Wheeler; Michael W Kattan; Y Goto; Peter T Scardino
Prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1995;154(5):1818-24.
1995: Makoto Ohori; J K Dunn; Peter T Scardino
Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?
Urology 1995;46(5):666-71.
1995: James A Eastham; Luan D Truong; E Rogers; Michael W Kattan; K C Flanders; Peter T Scardino; Timothy C Thompson
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):628-35.
1995: James A Eastham; A M Stapleton; Angelo E Gousse; Terry L Timme; Guang Yang; Kevin Slawin; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Association of p53 mutations with metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1111-8.
1995: A Arakawa; S Song; Peter T Scardino; Thomas M Wheeler
High grade prostatic intraepithelial neoplasia in prostates removed following irradiation failure in the treatment of prostatic adenocarcinoma.
Pathology, research and practice 1995;191(9):868-72.
1995: Bernard H Bochner; S P Lerner; M Kawachi; R D Williams; Peter T Scardino; Donald G Skinner
Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered?
Urology 1995;46(3):408-11.
1995: Bruce L Dalkin; Frederick R Ahmann; J B Kopp; William J Catalona; T L Ratliff; MA Hudson; J P Richie; Peter T Scardino; R C Flanigan; Jean B deKernion
Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma.
British journal of urology 1995;76(3):346-50.
1995: B J Miles; Peter T Scardino
Physicians, health care costs, and total quality management.
Journal of the American College of Surgeons 1995;180(5):604-6.
1995: E Rogers; Peter T Scardino
A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch.
The Journal of urology 1995;153(5):1432-8.
1995: Kevin Slawin; Makoto Ohori; O Dillioglugil; Peter T Scardino
Screening for prostate cancer: an analysis of the early experience.
CA: a cancer journal for clinicians 1995;45(3):134-47.
1995: damian greene; S R Taylor; M Aihara; K Yoshida; S Egawa; S H Park; Terry L Timme; Guang Yang; Peter T Scardino; Timothy C Thompson
DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
International journal of cancer. Journal international du cancer 1995;60(3):395-9.
1995: M Aihara; Peter T Scardino; Luan D Truong; Thomas M Wheeler; J R Goad; Guang Yang; Timothy C Thompson
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostate.
Cancer 1995;75(2):522-9.
1995: O Dillioglugil; B J Miles; Peter T Scardino
Current controversies in the management of localized prostate cancer.
European urology 1995;28(2):85-101.
1995: damian greene; John M Fitzpatrick; Peter T Scardino
Anatomy of the prostate and distribution of early prostate cancer.
Seminars in surgical oncology 1995;11(1):9-22.
1995: E Rogers; Makoto Ohori; V S Kassabian; Thomas M Wheeler; Peter T Scardino
Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
The Journal of urology 1995;153(1):104-10.
1994: William J Catalona; MA Hudson; Peter T Scardino; J P Richie; Frederick R Ahmann; R C Flanigan; Jean B deKernion; T L Ratliff; L R Kavoussi; Bruce L Dalkin
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
The Journal of urology 1994;152(6 Pt 1):2037-42.
1994: Peter T Scardino
Problem of prostate cancer.
The Journal of urology 1994;152(5 Pt 2):1677-8.
1994: Makoto Ohori; J R Goad; Thomas M Wheeler; James A Eastham; Timothy C Thompson; Peter T Scardino
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
The Journal of urology 1994;152(5 Pt 2):1843-9.
1994: Makoto Ohori; Thomas M Wheeler; J K Dunn; T A Stamey; Peter T Scardino
The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.
The Journal of urology 1994;152(5 Pt 2):1714-20.
1994: R C Flanigan; William J Catalona; J P Richie; Frederick R Ahmann; MA Hudson; Peter T Scardino; Jean B deKernion; T L Ratliff; L R Kavoussi; Bruce L Dalkin
Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer.
The Journal of urology 1994;152(5 Pt 1):1506-9.
1994: Makoto Ohori; Peter T Scardino
Early detection of prostate cancer: the nature of cancers detected with current diagnostic tests.
Seminars in oncology 1994;21(5):522-6.
1994: Mona Norberg; Christer Busch; J Stavinoha; Peter T Scardino; A Magnusson
Transrectal ultrasound-guided core biopsies of the prostate. A comparison between the standard 1.2-mm needle and three thinner needles.
Acta radiologica (Stockholm, Sweden : 1987) 1994;35(5):463-7.
1994: Peter T Scardino; C E Carlton
Re: Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.
The Journal of urology 1994;152(3):970.
1994: M Aihara; Luan D Truong; J K Dunn; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer.
Human pathology 1994;25(8):797-801.
1994: Makoto Ohori; S Egawa; K Shinohara; Thomas M Wheeler; Peter T Scardino
Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer.
British journal of urology 1994;74(1):72-9.
1994: Makoto Ohori; Thomas M Wheeler; Peter T Scardino
The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations.
Cancer 1994;74(1):104-14.
1994: Peter T Scardino; J R Beck; B J Miles
Conservative management of prostate cancer.
The New England journal of medicine 1994;330(25):1831; author reply 1831-2.
1994: M Aihara; R M Lebovitz; Thomas M Wheeler; B M Kinner; Makoto Ohori; Peter T Scardino
Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.
The Journal of urology 1994;151(6):1558-64.
1994: damian greene; E Rogers; E C Wessels; Thomas M Wheeler; S R Taylor; Richard A Santucci; Timothy C Thompson; Peter T Scardino
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
The Journal of urology 1994;151(5):1301-7.
1994: William J Catalona; J P Richie; Frederick R Ahmann; MA Hudson; Peter T Scardino; R C Flanigan; Jean B deKernion; T L Ratliff; L R Kavoussi; Bruce L Dalkin
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.
The Journal of urology 1994;151(5):1283-90.
1994: M Aihara; Thomas M Wheeler; Makoto Ohori; Peter T Scardino
Heterogeneity of prostate cancer in radical prostatectomy specimens.
Urology 1994;43(1):60-6; discussion 66-7.
1994: J Robert Beck; Peter T Scardino
How useful are models of natural history in clinical decision making and clinical research?
Journal of clinical epidemiology 1994;47(1):1-2.
1994: Thomas M Wheeler; E Rogers; M Aihara; Peter T Scardino; Timothy C Thompson
Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer.
Journal of cellular biochemistry. Supplement 1994;19():202-7.
1993: Makoto Ohori; Peter T Scardino; S L Lapin; C Seale-Hawkins; J Link; Thomas M Wheeler
The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer.
The American journal of surgical pathology 1993;17(12):1252-61.
1993: Makoto Ohori; K Shinohara; Thomas M Wheeler; M Aihara; E C Wessels; S S Carter; Peter T Scardino
Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study.
British journal of urology 1993;72(5 Pt 2):799-808.
1993: J R Goad; S J Chang; Makoto Ohori; Peter T Scardino
PSA after definitive radiotherapy for clinically localized prostate cancer.
The Urologic clinics of North America 1993;20(4):727-36.
1993: Kevin Slawin; Dov Kadmon; S H Park; Peter T Scardino; M Anzano; Michael B. Sporn; Timothy C Thompson
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system.
Cancer research 1993;53(19):4461-5.
1993: V S Kassabian; K Bottles; R Weaver; R D Williams; D F Paulson; Peter T Scardino
Possible mechanism for seeding of tumor during radical prostatectomy.
The Journal of urology 1993;150(4):1169-71.
1993: J P Richie; William J Catalona; Frederick R Ahmann; MA Hudson; Peter T Scardino; R C Flanigan; Jean B deKernion; T L Ratliff; L R Kavoussi; Bruce L Dalkin
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.
Urology 1993;42(4):365-74.
1993: Timothy C Thompson; Luan D Truong; Terry L Timme; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; S H Park
Transgenic models for the study of prostate cancer.
Cancer 1993;71(3 Suppl):1165-71.
1993: Makoto Ohori; Thomas M Wheeler; damian greene; Peter T Scardino
Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpation.
The Prostate 1993;23(4):271-81.
1993: Luan D Truong; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; Timothy C Thompson
Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study.
Human pathology 1993;24(1):4-9.
1992: Timothy C Thompson; S Egawa; Dov Kadmon; G J Miller; Terry L Timme; Peter T Scardino; S H Park
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
The Journal of steroid biochemistry and molecular biology 1992;43(1-3):79-85.
1992: S Egawa; S S Carter; Thomas M Wheeler; Peter T Scardino
Sonographic monitoring of prostate cancer after definitive radiotherapy.
Urology 1992;40(3):230-6.
1992: M A Rosen; L Goldstone; S Lapin; T Wheeler; Peter T Scardino
Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1992;148(2 Pt 1):331-7.
1992: David G Bostwick; W H Cooner; L Denis; G W Jones; Peter T Scardino; G P Murphy
The association of benign prostatic hyperplasia and cancer of the prostate.
Cancer 1992;70(1 Suppl):291-301.
1992: S Egawa; Thomas M Wheeler; damian greene; Peter T Scardino
Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy.
Urology 1992;39(4):358-63.
1992: Peter T Scardino; R Weaver; MA Hudson
Early detection of prostate cancer.
Human pathology 1992;23(3):211-22.
1992: S H Harrison; C Seale-Hawkins; C W Schum; J K Dunn; Peter T Scardino
Correlation between side of palpable tumor and side of pelvic lymph node metastasis in clinically localized prostate cancer.
Cancer 1992;69(3):750-4.
1992: S Egawa; Thomas M Wheeler; damian greene; Peter T Scardino
Unusual hyperechoic appearance of prostate cancer on transrectal ultrasonography.
British journal of urology 1992;69(2):169-74.
1992: S Egawa; Dov Kadmon; G J Miller; Peter T Scardino; Timothy C Thompson
Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
Molecular carcinogenesis 1992;5(1):52-61.
1992: Timothy C Thompson; Luan D Truong; Terry L Timme; Dov Kadmon; B K McCune; K C Flanders; Peter T Scardino; S H Park
Transforming growth factor beta 1 as a biomarker for prostate cancer.
Journal of cellular biochemistry. Supplement 1992;16H():54-61.
1991: M Holzman; C E Carlton; Peter T Scardino
The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer.
The Journal of urology 1991;146(6):1578-82.
1991: damian greene; Thomas M Wheeler; S Egawa; R P Weaver; Peter T Scardino
Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.
British journal of urology 1991;68(5):499-509.
1991: D L Lamm; B A Blumenstein; E D Crawford; James E Montie; Peter T Scardino; H B Grossman; T H Stanisic; J A Smith; J Sullivan; M F Sarosdy
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
The New England journal of medicine 1991;325(17):1205-9.
1991: damian greene; Thomas M Wheeler; S Egawa; J K Dunn; Peter T Scardino
A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate.
The Journal of urology 1991;146(4):1069-76.
1991: Seth P Lerner; C Seale-Hawkins; C E Carlton; Peter T Scardino
The risk of dying of prostate cancer in patients with clinically localized disease.
The Journal of urology 1991;146(4):1040-5.
1991: S Egawa; Thomas M Wheeler; Peter T Scardino
The sonographic appearance of irradiated prostate cancer.
British journal of urology 1991;68(2):172-7.
1991: S Egawa; damian greene; W F Flanagan; Thomas M Wheeler; Peter T Scardino
Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.
The Journal of urology 1991;146(2):366-71.
1991: Dov Kadmon; Timothy C Thompson; G R Lynch; Peter T Scardino
Elevated plasma chromogranin-A concentrations in prostatic carcinoma.
The Journal of urology 1991;146(2):358-61.
1991: damian greene; S R Taylor; Thomas M Wheeler; Peter T Scardino
DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
Cancer research 1991;51(15):4084-9.
1991: N K Iammarino; Peter T Scardino
Testicular cancer: the role of the primary care physician in prevention and early detection.
Texas medicine 1991;87(5):66-71.
1991: V W Merz; G J Miller; T Krebs; Terry L Timme; Dov Kadmon; S H Park; S Egawa; Peter T Scardino; Timothy C Thompson
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Molecular endocrinology (Baltimore, Md.) 1991;5(4):503-13.
1991: damian greene; S Egawa; G Neerhut; W Flanagan; Thomas M Wheeler; Peter T Scardino
The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.
The Journal of urology 1991;145(2):324-8; discussion 328-9.
1991: Peter T Scardino
What's new in surgery for 1991? Urology.
Bulletin of the American College of Surgeons 1991;76(1):59-62.
1991: Timothy C Thompson; Dov Kadmon; Terry L Timme; V W Merz; S Egawa; T Krebs; Peter T Scardino; S H Park
Experimental oncogene induced prostate cancer.
Cancer surveys 1991;11():55-71.
1990: W H Rawls; Donald L Lamm; B A Lowe; E D Crawford; Michael F Sarosdy; James E Montie; H B Grossman; Peter T Scardino
Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
The Journal of urology 1990;144(6):1328-30.
1990: damian greene; S Egawa; D K Hellerstein; Peter T Scardino
Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia.
Urology 1990;36(4):293-9.
1989: S Egawa; S S Carter; Thomas M Wheeler; Peter T Scardino
Ultrasonographic changes in the normal and malignant prostate after definitive radiotherapy.
The Urologic clinics of North America 1989;16(4):741-9.
1989: Peter T Scardino; K Shinohara; Thomas M Wheeler; S S Carter
Staging of prostate cancer. Value of ultrasonography.
The Urologic clinics of North America 1989;16(4):713-34.
1989: K Shinohara; Peter T Scardino; S S Carter; Thomas M Wheeler
Pathologic basis of the sonographic appearance of the normal and malignant prostate.
The Urologic clinics of North America 1989;16(4):675-91.
1989: Peter T Scardino
Early detection of prostate cancer.
The Urologic clinics of North America 1989;16(4):635-55.
1989: L A Gervasi; J Mata; J D Easley; J H Wilbanks; C Seale-Hawkins; C E Carlton; Peter T Scardino
Prognostic significance of lymph nodal metastases in prostate cancer.
The Journal of urology 1989;142(2 Pt 1):332-6.
1989: R B Meacham; Peter T Scardino; G S Hoffman; J D Easley; J H Wilbanks; C E Carlton
The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer.
The Journal of urology 1989;142(2 Pt 1):320-5.
1989: K Shinohara; Thomas M Wheeler; Peter T Scardino
The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.
The Journal of urology 1989;142(1):76-82.
1989: Peter T Scardino
Transrectal ultrasound in management of prostate cancer.
Urology 1989;33(6 Suppl):27-31.
1989: Peter T Scardino
Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer?
Progress in clinical and biological research 1989;303():223-39.
1989: Donald L Lamm; J Crissmann; B Blumenstein; E D Crawford; James E Montie; Peter T Scardino; H B Grossman; T Stanisic; J Smith; J Sullivan
Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.
Progress in clinical and biological research 1989;310():263-70.
1988: R B Meacham; J A Mata; Rafael Espada; Thomas M Wheeler; C W Schum; Peter T Scardino
Testicular metastasis as the first manifestation of colon carcinoma.
The Journal of urology 1988;140(3):621-2.
1988: G J Neerhut; T Wheeler; M Cantini; Peter T Scardino
Salvage radical prostatectomy for radiorecurrent adenocarcinoma of the prostate.
The Journal of urology 1988;140(3):544-9.
1988: G P Murphy; R L Priore; Peter T Scardino
Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.
Urology 1988;32(1):33-40.
1988: Charles Y F Young; Lata J Murthy; J L Prescott; M P Johnson; David R Rowley; Glenn R Cunningham; C S Killian; Peter T Scardino; A VonEschenbach; Donald J Tindall
Monoclonal antibodies against the androgen receptor: recognition of human and other mammalian androgen receptors.
Endocrinology 1988;123(1):601-10.
1988: Peter T Scardino; T M Wheeler
Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy.
NCI monographs : a publication of the National Cancer Institute 1988;(7):95-103.
1987: D Yu; T Pietro; S Jurco; Peter T Scardino
Identification of "tumor-associated" nucleolar antigens in human urothelial cancer.
The Journal of urology 1987;138(3):636-9.
1987: C E Carlton; Peter T Scardino
Combined interstitial and external irradiation for prostatic cancer.
Progress in clinical and biological research 1987;243B():141-69.
1986: J K Light; Peter T Scardino
Radical cystectomy with preservation of sexual and urinary function. Use of the ileocolonic pouch ("Le Bag").
The Urologic clinics of North America 1986;13(2):261-9.
1986: Peter T Scardino; J M Frankel; Thomas M Wheeler; R B Meacham; G S Hoffman; C Seale; J H Wilbanks; J Easley; C E Carlton
The prognostic significance of post-irradiation biopsy results in patients with prostatic cancer.
The Journal of urology 1986;135(3):510-6.
1986: A Fujino; Peter T Scardino
Transrectal ultrasonography for prostatic cancer. II. The response of the prostate to definitive radiotherapy.
Cancer 1986;57(5):935-40.
1986: Peter T Scardino
The treatment of localized prostatic cancer.
Scandinavian journal of urology and nephrology 1986;20(1):1-8.
1986: Lata J Murthy; M P Johnson; David R Rowley; Charles Y F Young; Peter T Scardino; Donald J Tindall
Characterization of steroid receptors in human prostate using mibolerone.
The Prostate 1986;8(3):241-53.
1985: J M Libby; J M Frankel; Peter T Scardino
Condyloma acuminatum of the bladder and associated urothelial malignancy.
The Journal of urology 1985;134(1):134-6.
1985: A Fujino; Peter T Scardino
Transrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapy.
The Journal of urology 1985;133(5):806-10.
1985: J E Gottesman; E D Crawford; H B Grossman; Peter T Scardino; J D McCracken
Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.
Urology 1985;25(3):248-50.
1985: Peter T Scardino; T M Wheeler
Prostatic biopsy after irradiation therapy for prostatic cancer.
Urology 1985;25(2 Suppl):39-46.
1984: Lata J Murthy; C H Chang; David R Rowley; Peter T Scardino; Donald J Tindall
Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
The Prostate 1984;5(6):567-79.
1983: Peter T Scardino
The prognostic significance of biopsies after radiotherapy for prostatic cancer.
Seminars in urology 1983;1(4):243-52.
1983: R P Gibbons; S Beckley; M F Brady; T M Chu; J B Dekernion; Chirpriya B Dhabuwala; J F Gaeta; S A Loening; C F McKiel; D G McLeod; J Edson Pontes; G R Prout; Peter T Scardino; J U Schlegel; J D Schmidt; W W Scott; N H Slack; Mark S Soloway; G P Murphy
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.
Journal of surgical oncology 1983;23(2):133-42.
1983: P G Wise; Peter T Scardino
Thoracoabdominal retroperitoneal lymphadenectomy for nonseminomatous testicular cancer.
The Urologic clinics of North America 1983;10(2):371-9.
1983: S A Loening; S Beckley; M F Brady; T M Chu; J B deKernion; Chirpriya B Dhabuwala; J F Gaeta; R P Gibbons; C F McKiel; D G McLeod; J Edson Pontes; G R Prout; Peter T Scardino; J U Schlegel; J D Schmidt; W W Scott; N H Slack; Mark S Soloway; G P Murphy
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
The Journal of urology 1983;129(5):1001-6.
1983: G P Murphy; S Beckley; M F Brady; T M Chu; J B deKernion; Chirpriya B Dhabuwala; J F Gaeta; R P Gibbons; S A Loening; C F McKiel; D G McLeod; J Edson Pontes; G R Prout; Peter T Scardino; J U Schlegel; J D Schmidt; W W Scott; N H Slack; Mark S Soloway
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
Cancer 1983;51(7):1264-72.
1983: K Fukutani; J M Libby; W B Panko; Peter T Scardino
Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.
The Journal of urology 1983;129(1):74-7.
1983: Mark S Soloway; S Beckley; M F Brady; T M Chu; J B deKernion; Chirpriya B Dhabuwala; J F Gaeta; R P Gibbons; S A Loening; C F McKiel; D G McLeod; J Edson Pontes; G R Prout; Peter T Scardino; J U Schlegel; J D Schmidt; W W Scott; N H Slack; G P Murphy
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
The Journal of urology 1983;129(1):56-61.
1982: David A Bloom; Peter T Scardino; R M Ehrlich; J Waisman
The significance of lymph nodal involvement in renal angiomyolipoma.
The Journal of urology 1982;128(6):1292-5.
1982: R M Ehrlich; Peter T Scardino
Surgical correction of scrotal transposition and perineal hypospadias.
Journal of pediatric surgery 1982;17(2):175-7.
1981: R M Ehrlich; Peter T Scardino
Simultaneous surgical correction of scrotal transposition and perineal hypospadias.
The Urologic clinics of North America 1981;8(3):531-7.
1981: D G Skinner; Peter T Scardino; J R Daniels
Testicular cancer.
Annual review of medicine 1981;32():543-57.
1980: Peter T Scardino
Adjuvant chemotherapy is of value following retroperitoneal lymph node dissection for nonseminomatous testicular tumors.
The Urologic clinics of North America 1980;7(3):735-45.
1980: P H Lange; L E Nochomovitz; J Rosai; E E Fraley; BJ Kennedy; George J Bosl; J Brisbane; W J Catalona; J S Cochran; R H Comisarow; K B Cummings; J B deKernion; L H Einhorn; T R Hakala; M Jewett; M R Moore; Peter T Scardino; J M Streitz
Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
The Journal of urology 1980;124(4):472-8.
1980: W E Goodwin; Peter T Scardino
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.
The Journal of urology 1980;123(3):370-4.
1980: D G Skinner; Peter T Scardino
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
The Journal of urology 1980;123(3):378-82.
1979: J S Ansell; R Boughton; T Cullen; C Hodges; E Nation; P Peters; Peter T Scardino
Lack of agreement between subjective ratings of instructors and objective testing of knowledge acquisition in a urological continuing medical education course.
The Journal of urology 1979;122(6):721-3.
1979: Robert J Kurman; Peter T Scardino; K R McIntire; Thomas Waldmann; N Javadpour; H J Norris
Malignant germ cell tumors of the ovary and testis. An immunohistologic study of 69 cases.
Annals of clinical and laboratory science 1979;9(6):462-6.
1979: Peter T Scardino; D G Skinner
Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Surgery 1979;86(1):86-93.
1979: W E Goodwin; Peter T Scardino
Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience.
Transactions of the American Association of Genito-Urinary Surgeons 1979;71():123-9.
1979: D G Skinner; Peter T Scardino
Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Transactions of the American Association of Genito-Urinary Surgeons 1979;71():31-5.
1978: M M Lieber; M Kunin; Peter T Scardino; J Waisman; F R Eilber; J J Kaufman
Innominate bone and renal masses in a young man.
The Journal of urology 1978;120(5):607-12.
1978: N Javadpour; K R McIntire; Thomas Waldmann; Peter T Scardino; S Bergman; T Anderson
The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
The Journal of urology 1978;119(6):759-62.
1977: Peter T Scardino; H D Cox; Thomas Waldmann; K R Mcintire; B Mittemeyer; N Javadpour
The value of serum tumor markers in the staging and prognosis of germ cell tumors of the testis.
The Journal of urology 1977;118(6):994-9.
1977: Robert J Kurman; Peter T Scardino; K R McIntire; Thomas Waldmann; N Javadpour
Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Cancer 1977;40(5):2136-51.
1977: J D Anderson; Peter T Scardino; R B Smith
Inflammatory fibrous histiocytoma presenting as a renal pelvic and bladder mass.
The Journal of urology 1977;118(3):470-1.
1977: W E Goodwin; Peter T Scardino
Ureterosigmoidostomy.
The Journal of urology 1977;118(1 Pt 2):169-74.
1977: R J Sukov; Peter T Scardino; W F Sample; J Winter; D J Confer
Computed tomography and transabdominal ultrasound in the evaluation of the prostate.
Journal of computer assisted tomography 1977;1(3):281-9.
1977: N Javadpour; Peter T Scardino
Recent advances in immunobiology of genitourinary cancer.
Urology 1977;9(4):377-84.
1976: N Javadpour; J L Doppman; Peter T Scardino; F C Bartter
Segmental renal vein renin assay and segmental nephrectomy for correction of renal hypertension.
The Journal of urology 1976;115(5):580-2.
1976: A Bernstein; Peter T Scardino; M M Tomaszewki; M H Cohen
Carcinoma arising in a branchial cleft cyst.
Cancer 1976;37(5):2417-22.
1975: Peter T Scardino; D H Bagley; N Javadpour; A S Ketcham
Sigmoid conduit urinary diversion.
Urology 1975;6(2):167-71.
1974: N Javadpour; C Hyatt; Peter T Scardino
Fetal antigens' cross-reactivity with transformed prostatic tissue.
Surgical forum 1974;25(0):98-9.
1973: Peter T Scardino; D F Paulson; J F Glenn
Transient significant bacteriuria in women.
The Journal of urology 1973;109(3):464-6.